<SEC-DOCUMENT>0001193125-15-261907.txt : 20150724
<SEC-HEADER>0001193125-15-261907.hdr.sgml : 20150724
<ACCEPTANCE-DATETIME>20150724062006
ACCESSION NUMBER:		0001193125-15-261907
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20150723
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150724
DATE AS OF CHANGE:		20150724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anthem, Inc.
		CENTRAL INDEX KEY:			0001156039
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				352145715
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16751
		FILM NUMBER:		151003386

	BUSINESS ADDRESS:	
		STREET 1:		120 MONUMENT CIRCLE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204
		BUSINESS PHONE:		3174886000

	MAIL ADDRESS:	
		STREET 1:		120 MONUMENT CIRCLE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT, INC
		DATE OF NAME CHANGE:	20100105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT INC
		DATE OF NAME CHANGE:	20041130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTHEM INC
		DATE OF NAME CHANGE:	20010730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d15785d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #bfbfbf">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #bfbfbf">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) of the Securities and Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Date of Report (Date of earliest event reported): July&nbsp;24, 2015 (July 23, 2015) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #bfbfbf">&nbsp;</P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ANTHEM, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of Registrant as specified in its Charter) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Indiana </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of Incorporation or Organization) </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>001-16751</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>35-2145715</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1.00pt solid #000000">(Commission File Number)</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:1.00pt solid #000000">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>120 Monument Circle </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Indianapolis, IN 46204 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Address of Principal Executive Offices, Including Zip Code) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(317) 488-6000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Registrant&#146;s telephone number, including area code) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Not applicable </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Former
name and former address, if changed since last report) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #bfbfbf">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;2.02&#151;Results of Operations and Financial Condition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Today, Anthem, Inc., an Indiana corporation (the &#147;Company&#148;), and Cigna Corporation, a Delaware corporation (&#147;Cigna&#148;), issued a joint press
release announcing that they have entered into an Agreement and Plan of Merger, dated as of July&nbsp;23, 2015 (the &#147;Merger Agreement&#148;), by and among the Company, Cigna and Anthem Merger Sub Corp., a Delaware corporation and a direct
wholly-owned subsidiary of the Company, pursuant to which the Company will acquire all outstanding shares of Cigna (the &#147;Acquisition&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
connection with the Acquisition, the Company is hosting a conference call today and making a presentation to investors to discuss the Acquisition and the Company will also preview on the conference call its second quarter 2015 net income of $3.13
per share, including net gains of $0.03 per share. Excluding these gains, adjusted net income was $3.10 per share for the second quarter. The Company now expects full year 2015 net income to be greater than $9.75&nbsp;per share, including greater
than $0.25&nbsp;per share of net unfavorable adjustment items. Excluding these items, adjusted net income is expected to be greater than $10.00 per share. This guidance does not include any future merger related transaction costs, which the Company
expects to exclude in its adjusted net income calculation, and does not include net adjustment items beyond those to be reported in the Company&#146;s second quarter 2015 earnings release, which are listed in the table below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B>Full Year 2015<B></B><br><B></B><B></B>Outlook<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income per diluted share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Greater than $9.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add / (Subtract) - net of related tax effects:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net realized gains on investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">($0.33)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other-than-temporary impairment losses on investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on extinguishment of debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of other intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Greater&nbsp;than&nbsp;$0.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-size:4pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net adjustment items</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Greater than $0.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-size:4pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net income per diluted share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Greater&nbsp;than&nbsp;$10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-size:4pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will provide additional details on its financial results on its quarterly earnings conference call on Wednesday,
July&nbsp;29th. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the investor presentation will be available this morning for download at the Company&#146;s website (<U>www.antheminc.com</U>).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the joint press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.03&#151; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;23, 2015, the Board of Directors of the Company approved an amendment to the By-Laws of the Company (the &#147;By-Law Amendment&#148;), which
became effective immediately. The By-Law Amendment added a new Article XI, which designates the Marion Superior Court in the State of Indiana (or, if the Marion Superior Court lacks jurisdiction, the United States District Court for the Southern
District of Indiana) as the sole and exclusive forum for </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certain legal action, unless the Company consents in writing to the selection of an alternative forum. The foregoing description of the By-Law Amendment is only a summary, does not purport to be
complete, and is qualified in its entirety by reference to the By-Law Amendment, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01&#151;Regulation FD Disclosure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
information set forth in Item&nbsp;2.02 of this Current Report on Form 8-K is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01&#151;Other Events
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item&nbsp;2.02 of this Current Report on Form 8-K is incorporated herein by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by Item&nbsp;1.01, including a copy of the Merger Agreement, will be filed in a separate Current Report on Form 8-K. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the information furnished in Item&nbsp;2.02, Item&nbsp;7.01, Item&nbsp;8.01 or Exhibit 99.1 hereto shall be deemed to be &#147;filed&#148; for
purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under
the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information for Investors and Shareholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication does not constitute an offer to sell or a solicitation of an offer to sell or a solicitation of an offer to buy any securities or a
solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed transaction between Anthem, Inc. (&#147;Anthem&#148;) and Cigna Corporation (&#147;Cigna&#148;) will be submitted to Anthem&#146;s and
Cigna&#146;s shareholders and stockholders (as applicable) for their consideration. In connection with the transaction, Anthem and Cigna will file relevant materials with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;), including
an Anthem registration statement on Form S-4 that will include a joint proxy statement of Anthem and Cigna that also constitutes a prospectus of Anthem, and each will mail the definitive joint proxy statement/prospectus to its shareholders and
stockholders, respectively. This communication is not a substitute for the registration statement, joint proxy statement/prospectus or any other document that Anthem and/or Cigna may file with the SEC in connection with the proposed transaction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INVESTORS AND SECURITY HOLDERS OF ANTHEM AND CIGNA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC
CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the registration statement containing the joint
proxy statement/prospectus and other documents filed with the SEC by Anthem or Cigna (when available) through the web site maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Anthem will be available free of
charge on Anthem&#146;s internet website at http://www.antheminc.com or by contacting Anthem&#146;s Investor Relations Department at (317) 488-6168. Copies of the documents filed with the SEC by Cigna will be available free of charge on Cigna&#146;s
internet website at http://www.cigna.com or by contacting Cigna&#146;s Investor Relations Department at (215) 761-4198. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem, Cigna and their
respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. You can find information about Anthem&#146;s executive
officers and directors in Anthem&#146;s annual report on Form 10-K for the year ended December 31, 2014 and its definitive proxy statement filed with the SEC on April 1, 2015. You can find information about Cigna&#146;s executive officers and
directors in Cigna&#146;s annual report on Form 10-K for the year ended December 31, 2014 and its definitive proxy statement filed with the SEC on March 13, 2015. Additional information regarding the interests of such potential participants will be
included in the joint proxy statement/prospectus when it is filed with the SEC. You may obtain free copies of these documents using the sources indicated above. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This document, and oral statements made with respect to information contained in this communication, </I><I>c</I><I>ontain </I><I>ce</I><I>rtain
for</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing i</I><I>n</I><I>formation about Anth</I><I>e</I><I>m, </I><I>I</I><I>n</I><I>c</I><I>.</I><I> </I><I>(</I><I>&#147;</I><I>Anth</I><I>e</I><I>m</I><I>&#148;</I><I>)</I><I>, </I><I>C</I><I>igna
</I><I>C</I><I>orporation </I><I>(</I><I>&#147;C</I><I>igna</I><I>&#148;</I><I>)</I><I> </I><I>and the</I><I> c</I><I>ombin</I><I>e</I><I>d busin</I><I>e</I><I>s</I><I>s</I><I>e</I><I>s of Anth</I><I>e</I><I>m and </I><I>C</I><I>igna that is
int</I><I>e</I><I>nd</I><I>e</I><I>d to be </I><I>c</I><I>o</I><I>ve</I><I>r</I><I>e</I><I>d </I><I>b</I><I>y</I><I> </I><I>the</I><I> </I><I>safe</I><I> </I><I>har</I><I>b</I><I>or for
</I><I>&#147;</I><I>for</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing</I><I> </I><I>stat</I><I>e</I><I>m</I><I>e</I><I>nts&#148;</I><I> </I><I>pro</I><I>v</I><I>id</I><I>e</I><I>d by</I><I> </I><I>the</I><I>
</I><I>Pri</I><I>v</I><I>ate</I><I> </I><I>S</I><I>ec</I><I>uriti</I><I>e</I><I>s </I><I>L</I><I>itigation R</I><I>e</I><I>form A</I><I>c</I><I>t of</I><I> </I><I>1995. For</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing
stat</I><I>e</I><I>m</I><I>e</I><I>nts are</I><I> </I><I>stat</I><I>e</I><I>m</I><I>e</I><I>nts</I><I> </I><I>that are</I><I> </I><I>not g</I><I>e</I><I>n</I><I>e</I><I>rally histori</I><I>c</I><I>al fa</I><I>c</I><I>ts.</I><I> </I><I>W</I><I>ords
su</I><I>c</I><I>h as </I><I>&#147;</I><I>ex</I><I>p</I><I>ec</I><I>t</I><I>(</I><I>s</I><I>)</I><I>,&#148;</I><I> &#147;</I><I>f</I><I>ee</I><I>l</I><I>(</I><I>s</I><I>)</I><I>,&#148;</I><I>
&#147;</I><I>b</I><I>e</I><I>li</I><I>e</I><I>ve</I><I>(</I><I>s</I><I>)</I><I>,&#148;</I><I> &#147;w</I><I>ill,&#148;</I><I> </I><I>&#147;</I><I>ma</I><I>y</I><I>,&#148;</I><I>
&#147;</I><I>anti</I><I>c</I><I>ipat</I><I>e</I><I>(</I><I>s</I><I>)</I><I>,&#148; </I><I>&#147;</I><I>int</I><I>e</I><I>nd,&#148;</I><I> &#147;</I><I>e</I><I>stimat</I><I>e</I><I>,&#148;</I><I>
</I><I>&#147;</I><I>p</I><I>roj</I><I>ec</I><I>t&#148;</I><I> </I><I>and similar </I><I>ex</I><I>pr</I><I>e</I><I>ssions </I><I>(</I><I>in</I><I>c</I><I>luding the</I><I> </I><I>n</I><I>e</I><I>g</I><I>ati</I><I>v</I><I>e</I><I>
</I><I>th</I><I>e</I><I>r</I><I>e</I><I>o</I><I>f</I><I>)</I><I> </I><I>are</I><I> </I><I>int</I><I>e</I><I>n</I><I>d</I><I>e</I><I>d to id</I><I>e</I><I>ntify</I><I> </I><I>for</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>i</I><I>ng
stat</I><I>e</I><I>m</I><I>e</I><I>nts, </I><I>w</I><I>hi</I><I>c</I><I>h g</I><I>e</I><I>n</I><I>e</I><I>rally</I><I> </I><I>are</I><I> </I><I>not histori</I><I>c</I><I>al in natur</I><I>e</I><I>. </I><I>T</I><I>h</I><I>e</I><I>se</I><I>
</I><I>stat</I><I>e</I><I>m</I><I>e</I><I>n</I><I>ts in</I><I>c</I><I>lud</I><I>e</I><I>, but are</I><I> </I><I>not limit</I><I>e</I><I>d to, stat</I><I>e</I><I>m</I><I>e</I><I>nts r</I><I>e</I><I>garding the merger between Anthem and
</I><I>C</I><I>igna;</I><I> </I><I>Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s finan</I><I>c</I><I>ing of the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion;</I><I> </I><I>the combined company&#146;s</I><I>
</I><I>ex</I><I>p</I><I>e</I><I>c</I><I>t</I><I>e</I><I>d future</I><I> </I><I>p</I><I>e</I><I>rform</I><I>a</I><I>n</I><I>c</I><I>e</I><I> </I><I>(</I><I>in</I><I>c</I><I>luding </I><I>e</I><I>x</I><I>p</I><I>ec</I><I>t</I><I>e</I><I>d
r</I><I>e</I><I>sults of op</I><I>e</I><I>rations and</I><I> </I><I>finan</I><I>c</I><I>ial guidan</I><I>ce)</I><I>;</I><I> </I><I>the</I><I> </I><I>c</I><I>ombin</I><I>e</I><I>d </I><I>c</I><I>ompa</I><I>n</I><I>y&#146;</I><I>s
fu</I><I>t</I><I>ure</I><I> </I><I>finan</I><I>c</I><I>ial </I><I>c</I><I>ondition, op</I><I>e</I><I>rating r</I><I>e</I><I>sults, strat</I><I>e</I><I>g</I><I>y</I><I> </I><I>and plans;</I><I> statements about regulatory and other approvals;
</I><I>s</I><I>y</I><I>n</I><I>e</I><I>rgi</I><I>e</I><I>s f</I><I>r</I><I>om the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion;</I><I> the combined company&#146;s expected debt-to-capital ratio and ability to retain investment
grade ratings; </I><I>the</I><I> c</I><I>losing date</I><I> </I><I>for the propos</I><I>e</I><I>d transa</I><I>c</I><I>tion;</I><I> </I><I>finan</I><I>c</I><I>ial proj</I><I>ec</I><I>tions and </I><I>e</I><I>stimat</I><I>e</I><I>s and
th</I><I>e</I><I>ir und</I><I>e</I><I>rl</I><I>y</I><I>ing assumptions; stat</I><I>e</I><I>m</I><I>e</I><I>nts r</I><I>e</I><I>garding plans, obj</I><I>ec</I><I>ti</I><I>ve</I><I>s and </I><I>e</I><I>x</I><I>p</I><I>ec</I><I>t</I><I>ations
</I><I>w</I><I>ith r</I><I>e</I><I>sp</I><I>ec</I><I>t to fu</I><I>t</I><I>ure</I><I> </I><I>op</I><I>e</I><I>rations, produ</I><I>c</I><I>ts and s</I><I>e</I><I>r</I><I>v</I><I>i</I><I>ce</I><I>s;</I><I> </I><I>and
stat</I><I>e</I><I>m</I><I>e</I><I>nts r</I><I>e</I><I>garding future</I><I> </I><I>p</I><I>e</I><I>rforman</I><I>ce</I><I>. Su</I><I>c</I><I>h stat</I><I>e</I><I>m</I><I>e</I><I>n</I><I>ts are</I><I> </I><I>subj</I><I>ec</I><I>t to
</I><I>ce</I><I>rtain </I><I>k</I><I>no</I><I>w</I><I>n and un</I><I>k</I><I>no</I><I>w</I><I>n ris</I><I>k</I><I>s and un</I><I>ce</I><I>rtainti</I><I>e</I><I>s, many</I><I> </I><I>of </I><I>w</I><I>hi</I><I>c</I><I>h are</I><I>
</I><I>diffi</I><I>c</I><I>ult to</I><I> </I><I>pr</I><I>e</I><I>di</I><I>c</I><I>t and g</I><I>e</I><I>n</I><I>e</I><I>rally b</I><I>ey</I><I>ond Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s and </I><I>C</I><I>igna</I><I>&#146;</I><I>s
</I><I>c</I><I>ontrol, that </I><I>c</I><I>ould </I><I>c</I><I>ause</I><I> </I><I>a</I><I>c</I><I>tual r</I><I>e</I><I>sults and oth</I><I>e</I><I>r future</I><I> eve</I><I>nts to diff</I><I>e</I><I>r mat</I><I>e</I><I>rially</I><I> </I><I>from
those</I><I> e</I><I>x</I><I>pr</I><I>e</I><I>ss</I><I>e</I><I>d in, or impli</I><I>e</I><I>d or proj</I><I>ec</I><I>t</I><I>e</I><I>d b</I><I>y</I><I>, the</I><I> </I><I>for</I><I>w</I><I>ar</I><I>d</I><I>-</I><I>loo</I><I>k</I><I>ing information
and stat</I><I>e</I><I>m</I><I>e</I><I>nts. </I><I>T</I><I>h</I><I>e</I><I>se</I><I> </I><I>ris</I><I>k</I><I>s and un</I><I>ce</I><I>rtainti</I><I>e</I><I>s in</I><I>c</I><I>lud</I><I>e</I><I>:</I><I> </I><I>those</I><I>
</I><I>dis</I><I>c</I><I>uss</I><I>e</I><I>d and id</I><I>e</I><I>n</I><I>tifi</I><I>e</I><I>d in Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s and </I><I>C</I><I>igna</I><I>&#146;</I><I>s public</I><I> </I><I>filings</I><I>
</I><I>w</I><I>i</I><I>t</I><I>h the</I><I> </I><I>U.S. S</I><I>ec</I><I>uriti</I><I>e</I><I>s and</I><I> </I><I>E</I><I>xc</I><I>hange</I><I> </I><I>C</I><I>ommission</I><I> </I><I>(</I><I>t</I><I>he</I><I>
</I><I>&#147;</I><I>SE</I><I>C&#148;</I><I>)</I><I>;</I><I> </I><I>those</I><I> </I><I>r</I><I>e</I><I>lati</I><I>n</I><I>g to the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion, as d</I><I>e</I><I>tail</I><I>e</I><I>d from
time</I><I> </I><I>to time</I><I> </I><I>in Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s and </I><I>C</I><I>igna</I><I>&#146;</I><I>s filings </I><I>w</I><I>ith the SE</I><I>C</I><I>;</I><I> </I><I>in</I><I>c</I><I>r</I><I>e</I><I>as</I><I>e</I><I>d
go</I><I>v</I><I>e</I><I>rn</I><I>m</I><I>e</I><I>nt parti</I><I>c</I><I>ipation in, or r</I><I>e</I><I>gulation or ta</I><I>x</I><I>ation of h</I><I>e</I><I>alth b</I><I>e</I><I>n</I><I>e</I><I>fits and manag</I><I>e</I><I>d
</I><I>c</I><I>are</I><I> </I><I>op</I><I>e</I><I>rations, in</I><I>c</I><I>luding, but not limit</I><I>e</I><I>d to, the</I><I> </I><I>i</I><I>mpa</I><I>c</I><I>t of the</I><I> </I><I>Pati</I><I>e</I><I>nt Prot</I><I>ec</I><I>tion and
Affordable</I><I> </I><I>C</I><I>are A</I><I>c</I><I>t and the</I><I> </I><I>H</I><I>e</I><I>alth </I><I>C</I><I>are</I><I> </I><I>and Edu</I><I>c</I><I>ation R</I><I>ec</I><I>on</I><I>c</I><I>il</I><I>i</I><I>ation A</I><I>c</I><I>t of 2010, or
H</I><I>e</I><I>alth </I><I>C</I><I>are</I><I> </I><I>R</I><I>e</I><I>form;</I><I> </I><I>tr</I><I>e</I><I>nds in h</I><I>e</I><I>alth </I><I>c</I><I>are</I><I> c</I><I>osts and utilization rat</I><I>e</I><I>s;</I><I> </I><I>our ability</I><I>
</I><I>to s</I><I>ec</I><I>ure</I><I> </I><I>suffi</I><I>c</I><I>i</I><I>e</I><I>nt pr</I><I>e</I><I>mium rat</I><I>e</I><I>s in</I><I>c</I><I>luding r</I><I>e</I><I>gulatory</I><I> </I><I>appro</I><I>v</I><I>al for and
impl</I><I>e</I><I>m</I><I>e</I><I>ntation of su</I><I>c</I><I>h rat</I><I>e</I><I>s;</I><I> </I><I>our parti</I><I>c</I><I>ipation in the</I><I> </I><I>f</I><I>e</I><I>d</I><I>e</I><I>ral and state</I><I> </I><I>h</I><I>e</I><I>alth
insuran</I><I>c</I><I>e</I><I> e</I><I>x</I><I>c</I><I>hang</I><I>e</I><I>s und</I><I>e</I><I>r </I><I>H</I><I>e</I><I>alth </I><I>C</I><I>are</I><I> </I><I>R</I><I>e</I><I>form, </I><I>w</I><I>hi</I><I>c</I><I>h ha</I><I>v</I><I>e</I><I>
</I><I>ex</I><I>p</I><I>e</I><I>ri</I><I>e</I><I>n</I><I>ce</I><I>d and </I><I>c</I><I>ontin</I><I>u</I><I>e</I><I> </I><I>to </I><I>ex</I><I>p</I><I>e</I><I>ri</I><I>e</I><I>n</I><I>c</I><I>e</I><I>
c</I><I>hall</I><I>e</I><I>n</I><I>g</I><I>e</I><I>s d</I><I>u</I><I>e</I><I> </I><I>to impl</I><I>e</I><I>m</I><I>e</I><I>ntation of initial and phas</I><I>e</I><I>d</I><I>-</I><I>in pro</I><I>v</I><I>isions of H</I><I>e</I><I>alth
</I><I>C</I><I>are R</I><I>e</I><I>form, and </I><I>w</I><I>hi</I><I>c</I><I>h </I><I>e</I><I>ntail un</I><I>ce</I><I>rtainti</I><I>e</I><I>s asso</I><I>c</I><I>iat</I><I>e</I><I>d </I><I>w</I><I>ith the</I><I> </I><I>mix</I><I> </I><I>and
</I><I>v</I><I>olume</I><I> </I><I>of busin</I><I>e</I><I>ss, parti</I><I>c</I><I>ularly</I><I> </I><I>in </I><I>I</I><I>ndi</I><I>v</I><I>idual and</I><I> </I><I>Small Group mar</I><I>ke</I><I>ts, that </I><I>c</I><I>ould
n</I><I>e</I><I>gati</I><I>ve</I><I>ly</I><I> </I><I>imp</I><I>a</I><I>c</I><I>t the</I><I> </I><I>ad</I><I>e</I><I>qua</I><I>c</I><I>y</I><I> </I><I>of our pr</I><I>e</I><I>mium rat</I><I>e</I><I>s and </I><I>w</I><I>hi</I><I>c</I><I>h may</I><I>
</I><I>not be</I><I> </I><I>suffi</I><I>c</I><I>i</I><I>e</I><I>ntly</I><I> </I><I>o</I><I>ffs</I><I>e</I><I>t by</I><I> </I><I>the</I><I> </I><I>risk</I><I> </I><I>apportionm</I><I>e</I><I>nt pro</I><I>v</I><I>isions of H</I><I>e</I><I>alth
</I><I>C</I><I>are</I><I> </I><I>R</I><I>e</I><I>form;</I><I> </I><I>our ability</I><I> </I><I>to </I><I>c</I><I>ontra</I><I>c</I><I>t </I><I>w</I><I>ith </I><I>p</I><I>ro</I><I>v</I><I>id</I><I>e</I><I>rs </I><I>c</I><I>onsist</I><I>e</I><I>nt
</I><I>w</I><I>ith past pra</I><I>c</I><I>ti</I><I>ce</I><I>;</I><I> c</I><I>om</I><I>p</I><I>e</I><I>titor pri</I><I>c</I><I>ing b</I><I>e</I><I>low</I><I> </I><I>mar</I><I>ke</I><I>t tr</I><I>e</I><I>nds of in</I><I>c</I><I>r</I><I>e</I><I>asing
</I><I>c</I><I>osts;</I><I> </I><I>r</I><I>e</I><I>du</I><I>ce</I><I>d</I><I> </I><I>e</I><I>nrollm</I><I>e</I><I>nt, as </I><I>w</I><I>e</I><I>ll as a n</I><I>e</I><I>gati</I><I>v</I><I>e</I><I> c</I><I>hange</I><I> </I><I>i</I><I>n our
h</I><I>e</I><I>alth </I><I>c</I><I>are</I><I> </I><I>pr</I><I>o</I><I>du</I><I>c</I><I>t mi</I><I>x</I><I>;</I><I> </I><I>ris</I><I>k</I><I>s and un</I><I>c</I><I>e</I><I>r</I><I>tainti</I><I>e</I><I>s r</I><I>e</I><I>garding
</I><I>Me</I><I>di</I><I>c</I><I>are</I><I> </I><I>and </I><I>Me</I><I>di</I><I>c</I><I>aid programs, in</I><I>c</I><I>luding tho</I><I>s</I><I>e</I><I> </I><I>r</I><I>e</I><I>lat</I><I>e</I><I>d to
non</I><I>-c</I><I>ompli</I><I>a</I><I>n</I><I>c</I><I>e</I><I> </I><I>w</I><I>ith the</I><I> c</I><I>ompl</I><I>e</I><I>x</I><I> </I><I>r</I><I>e</I><I>g</I><I>ulations impos</I><I>e</I><I>d th</I><I>e</I><I>r</I><I>e</I><I>on and funding
ris</I><I>k</I><I>s </I><I>w</I><I>ith r</I><I>e</I><I>sp</I><I>ec</I><I>t to r</I><I>eve</I><I>n</I><I>u</I><I>e</I><I> </I><I>r</I><I>e</I><I>c</I><I>e</I><I>i</I><I>ve</I><I>d</I><I> </I><I>from parti</I><I>c</I><I>ipation
th</I><I>e</I><I>r</I><I>e</I><I>i</I><I>n;</I><I> our projected consolidated revenue growth and global medical customer growth; </I><I>a do</I><I>w</I><I>ngrade</I><I> </I><I>in our finan</I><I>c</I><I>ial str</I><I>e</I><I>ngth ratings;</I><I>
</I><I>litig</I><I>a</I><I>tion a</I><I>n</I><I>d in</I><I>ve</I><I>stigations targ</I><I>e</I><I>t</I><I>e</I><I>d at our industry</I><I> </I><I>and our ability</I><I> </I><I>to r</I><I>e</I><I>sol</I><I>v</I><I>e</I><I> </I><I>litigation and
in</I><I>ve</I><I>stigations </I><I>w</I><I>ithin </I><I>e</I><I>s</I><I>t</I><I>imat</I><I>e</I><I>s;</I><I> </I><I>m</I><I>e</I><I>di</I><I>c</I><I>al malpra</I><I>c</I><I>ti</I><I>c</I><I>e</I><I> </I><I>or prof</I><I>e</I><I>ssional
liabi</I><I>l</I><I>ity</I><I> c</I><I>laims or oth</I><I>e</I><I>r ris</I><I>k</I><I>s r</I><I>e</I><I>lat</I><I>e</I><I>d to h</I><I>e</I><I>alth </I><I>c</I><I>are</I><I> </I><I>s</I><I>e</I><I>r</I><I>v</I><I>i</I><I>c</I><I>e</I><I>s
pro</I><I>v</I><I>id</I><I>e</I><I>d by</I><I> </I><I>our subsidiari</I><I>e</I><I>s;</I><I> </I><I>our ability</I><I> </I><I>to r</I><I>e</I><I>pur</I><I>c</I><I>hase</I><I> </I><I>shar</I><I>e</I><I>s of its </I><I>c</I><I>ommon
sto</I><I>c</I><I>k</I><I> </I><I>a</I><I>nd pay</I><I> </I><I>di</I><I>v</I><I>id</I><I>e</I><I>nds on its </I><I>c</I><I>ommon sto</I><I>c</I><I>k</I><I> </I><I>d</I><I>u</I><I>e</I><I> </I><I>to the</I><I>
</I><I>ad</I><I>e</I><I>qua</I><I>c</I><I>y</I><I> </I><I>of its </I><I>c</I><I>ash flow</I><I> </I><I>and </I><I>e</I><I>arnings and oth</I><I>e</I><I>r </I><I>c</I><I>onsid</I><I>e</I><I>rations;</I><I>
</I><I>non-</I><I>c</I><I>omplian</I><I>c</I><I>e</I><I> </I><I>by</I><I> </I><I>a</I><I>n</I><I>y</I><I> </I><I>party</I><I> w</I><I>ith the</I><I> </I><I>E</I><I>x</I><I>pr</I><I>e</I><I>ss S</I><I>c</I><I>ripts, </I><I>I</I><I>n</I><I>c</I><I>.
pharma</I><I>c</I><I>y</I><I> </I><I>b</I><I>e</I><I>n</I><I>e</I><I>fit m</I><I>a</I><I>nag</I><I>e</I><I>m</I><I>e</I><I>nt s</I><I>e</I><I>r</I><I>v</I><I>i</I><I>ce</I><I>s agr</I><I>ee</I><I>m</I><I>e</I><I>nt, </I><I>w</I><I>hi</I><I>c</I><I>h
</I><I>c</I><I>ould </I><I>r</I><I>e</I><I>sult in finan</I><I>c</I><I>ial p</I><I>e</I><I>nalti</I><I>e</I><I>s;</I><I> </I><I>our inability</I><I> </I><I>to m</I><I>ee</I><I>t </I><I>c</I><I>ustom</I><I>e</I><I>r </I><I>d</I><I>e</I><I>mands, and
san</I><I>c</I><I>tions impos</I><I>e</I><I>d by</I><I> </I><I>go</I><I>ve</I><I>rn</I><I>m</I><I>e</I><I>ntal </I><I>e</I><I>ntiti</I><I>e</I><I>s, in</I><I>c</I><I>luding the</I><I> </I><I>C</I><I>e</I><I>nt</I><I>e</I><I>rs for
</I><I>Me</I><I>di</I><I>c</I><I>are</I><I> </I><I>and</I><I> </I><I>Me</I><I>di</I><I>c</I><I>aid S</I><I>e</I><I>r</I><I>v</I><I>i</I><I>ce</I><I>s;</I><I> </I><I>e</I><I>v</I><I>e</I><I>nts that r</I><I>e</I><I>sult in
n</I><I>e</I><I>gati</I><I>v</I><I>e</I><I> </I><I>publi</I><I>c</I><I>ity</I><I> </I><I>for us or the</I><I> </I><I>h</I><I>e</I><I>alth b</I><I>e</I><I>n</I><I>e</I><I>fits industr</I><I>y</I><I>;</I><I> </I><I>failure</I><I> </I><I>to
</I><I>e</I><I>ff</I><I>ec</I><I>ti</I><I>ve</I><I>ly</I><I> </I><I>maintain and</I><I> </I><I>mod</I><I>e</I><I>rnize</I><I> </I><I>our inf</I><I>o</I><I>rmation s</I><I>y</I><I>st</I><I>e</I><I>ms and </I><I>e-</I><I>b</I><I>usin</I><I>e</I><I>ss
organization and</I><I> </I><I>to maintain good r</I><I>e</I><I>lations</I><I>h</I><I>ips </I><I>w</I><I>ith th</I><I>i</I><I>rd party</I><I> ve</I><I>ndors for information s</I><I>y</I><I>st</I><I>e</I><I>m
r</I><I>e</I><I>sour</I><I>ce</I><I>s;</I><I> </I><I>e</I><I>v</I><I>e</I><I>nts that may</I><I> </I><I>n</I><I>e</I><I>gati</I><I>ve</I><I>l</I><I>y</I><I> </I><I>aff</I><I>ec</I><I>t An</I><I>t</I><I>h</I><I>e</I><I>m</I><I>&#146;</I><I>s
li</I><I>ce</I><I>ns</I><I>e</I><I>s </I><I>w</I><I>ith the</I><I> </I><I>B</I><I>lue</I><I> </I><I>C</I><I>ross and Blue</I><I> </I><I>Shi</I><I>e</I><I>ld Asso</I><I>c</I><I>iation;</I><I> </I><I>possible impairm</I><I>e</I><I>nt of the</I><I>
v</I><I>alue</I><I> </I><I>of our intangible</I><I> </I><I>ass</I><I>e</I><I>ts if future</I><I> </I><I>r</I><I>e</I><I>sults do</I><I> </I><I>not ad</I><I>e</I><I>quat</I><I>e</I><I>ly</I><I> </I><I>support good</I><I>w</I><I>ill and
oth</I><I>e</I><I>r inta</I><I>n</I><I>gible</I><I> </I><I>ass</I><I>e</I><I>ts;</I><I> </I><I>int</I><I>e</I><I>nse</I><I> c</I><I>o</I><I>m</I><I>p</I><I>e</I><I>tition to attra</I><I>c</I><I>t and r</I><I>e</I><I>t</I><I>ain
</I><I>e</I><I>mplo</I><I>yee</I><I>s</I><I>; unauthoriz</I><I>e</I><I>d dis</I><I>c</I><I>losure</I><I> </I><I>of m</I><I>e</I><I>mb</I><I>e</I><I>r or </I><I>e</I><I>mpl</I><I>o</I><I>ye</I><I>e</I><I>
</I><I>s</I><I>e</I><I>nsiti</I><I>v</I><I>e</I><I> </I><I>or </I><I>c</I><I>onfid</I><I>e</I><I>ntial information, in</I><I>c</I><I>luding the impa</I><I>c</I><I>t and out</I><I>c</I><I>ome</I><I> </I><I>of i</I><I>n</I><I>ve</I><I>stigations,
inquiri</I><I>e</I><I>s, </I><I>c</I><I>laims and litigation r</I><I>e</I><I>lat</I><I>e</I><I>d to the</I><I> cy</I><I>b</I><I>e</I><I>r atta</I><I>c</I><I>k Anth</I><I>e</I><I>m r</I><I>e</I><I>port</I><I>e</I><I>d in
F</I><I>e</I><I>b</I><I>r</I><I>uary</I><I> </I><I>2015;</I><I> c</I><I>hang</I><I>e</I><I>s in t</I><I>h</I><I>e</I><I> ec</I><I>onom</I><I>i</I><I>c</I><I> </I><I>and mar</I><I>k</I><I>e</I><I>t </I><I>c</I><I>onditions, as
</I><I>w</I><I>e</I><I>ll as r</I><I>e</I><I>gulations that may</I><I> </I><I>n</I><I>e</I><I>gati</I><I>ve</I><I>ly</I><I> </I><I>aff</I><I>ec</I><I>t our i</I><I>n</I><I>ve</I><I>stm</I><I>e</I><I>nt portfolios and
l</I><I>i</I><I>quidit</I><I>y</I><I>;</I><I> </I><I>possible r</I><I>e</I><I>stri</I><I>c</I><I>tions in the</I><I> </I><I>pa</I><I>y</I><I>m</I><I>e</I><I>nt of di</I><I>v</I><I>id</I><I>e</I><I>nds by</I><I> </I><I>our subsidiari</I><I>e</I><I>s
and in</I><I>c</I><I>r</I><I>e</I><I>as</I><I>e</I><I>s in r</I><I>e</I><I>quir</I><I>e</I><I>d minim</I><I>u</I><I>m l</I><I>eve</I><I>ls of </I><I>c</I><I>apital and the</I><I> </I><I>pot</I><I>e</I><I>ntial
n</I><I>e</I><I>gati</I><I>v</I><I>e</I><I> e</I><I>ff</I><I>ec</I><I>t </I><I>f</I><I>rom our substantial amount of outstanding ind</I><I>e</I><I>bt</I><I>e</I><I>dn</I><I>e</I><I>ss;</I><I> </I><I>g</I><I>e</I><I>n</I><I>e</I><I>ral
ris</I><I>k</I><I>s asso</I><I>c</I><I>iat</I><I>e</I><I>d </I><I>w</I><I>ith m</I><I>e</I><I>rg</I><I>e</I><I>rs and a</I><I>c</I><I>quisitions;</I><I> v</I><I>arious la</I><I>w</I><I>s and pro</I><I>v</I><I>isions </I><I>i</I><I>n
Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s go</I><I>v</I><I>e</I><I>rning do</I><I>c</I><I>um</I><I>e</I><I>nts that may</I><I> </I><I>pr</I><I>e</I><I>v</I><I>e</I><I>nt or dis</I><I>c</I><I>ourage</I><I>
</I><I>ta</I><I>ke</I><I>o</I><I>v</I><I>e</I><I>rs</I><I> </I><I>and busin</I><I>e</I><I>ss </I><I>c</I><I>ombinations; future</I><I> </I><I>public</I><I> </I><I>h</I><I>e</I><I>alth </I><I>e</I><I>pid</I><I>e</I><I>mi</I><I>c</I><I>s and
</I><I>c</I><I>atastroph</I><I>e</I><I>s;</I><I> </I><I>and g</I><I>e</I><I>n</I><I>e</I><I>ral </I><I>ec</I><I>on</I><I>o</I><I>mic</I><I> </I><I>d</I><I>o</I><I>w</I><I>nturns. </I><I>I</I><I>mportant fa</I><I>c</I><I>t</I><I>o</I><I>rs that
</I><I>c</I><I>ould </I><I>c</I><I>ause</I><I> </I><I>a</I><I>c</I><I>tual r</I><I>e</I><I>sults and oth</I><I>e</I><I>r future</I><I> e</I><I>v</I><I>e</I><I>nts to diff</I><I>e</I><I>r mat</I><I>e</I><I>rially</I><I> </I><I>f</I><I>rom the</I><I>
</I><I>for</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing stat</I><I>e</I><I>m</I><I>e</I><I>nts made</I><I> </I><I>in this </I><I>c</I><I>ommuni</I><I>c</I><I>ation are</I><I> </I><I>s</I><I>e</I><I>t forth in oth</I><I>e</I><I>r
r</I><I>e</I><I>ports or do</I><I>c</I><I>um</I><I>e</I><I>nts that Anth</I><I>e</I><I>m and/or </I><I>C</I><I>igna may</I><I> </I><I>file</I><I> </I><I>from time</I><I> </I><I>to time</I><I> </I><I>w</I><I>ith the</I><I> </I><I>SE</I><I>C</I><I>,
a</I><I>n</I><I>d in</I><I>c</I><I>lud</I><I>e</I><I>, but are</I><I> </I><I>not limit</I><I>e</I><I>d to:</I><I> </I><I>(</I><I>i</I><I>)</I><I> </I><I>t</I><I>h</I><I>e</I><I> </I><I>ultimate out</I><I>c</I><I>ome</I><I> </I><I>of the</I><I>
</I><I>propos</I><I>e</I><I>d</I><I> </I><I>transa</I><I>c</I><I>tion, in</I><I>c</I><I>luding the ability</I><I> </I><I>to a</I><I>c</I><I>hi</I><I>ev</I><I>e</I><I> </I><I>the</I><I> </I><I>s</I><I>y</I><I>n</I><I>e</I><I>rgi</I><I>e</I><I>s and
</I><I>v</I><I>alue</I><I> c</I><I>r</I><I>e</I><I>ation </I><I>c</I><I>ont</I><I>e</I><I>mplat</I><I>e</I><I>d by</I><I> </I><I>the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion, </I><I>(</I><I>i</I><I>i</I><I>)</I><I>
</I><I>the</I><I> </I><I>ultimate</I><I> </I><I>out</I><I>c</I><I>o</I><I>me</I><I> </I><I>and r</I><I>e</I><I>sults of int</I><I>e</I><I>grating the</I><I> </I><I>op</I><I>e</I><I>rations of Anthem and </I><I>C</I><I>igna,
</I><I>(</I><I>iii)</I><I> </I><I>disruption from the</I><I> </I><I>m</I><I>e</I><I>rg</I><I>e</I><I>r m</I><I>a</I><I>k</I><I>ing it more</I><I> </I><I>diffi</I><I>c</I><I>ult to mainta</I><I>i</I><I>n busin</I><I>e</I><I>ss</I><I>e</I><I>s and
op</I><I>e</I><I>rational r</I><I>e</I><I>lationships, </I><I>(</I><I>i</I><I>v</I><I>)</I><I> </I><I>the</I><I> </I><I>risk</I><I> </I><I>that un</I><I>ex</I><I>p</I><I>ec</I><I>t</I><I>e</I><I>d</I><I> </I><I>c</I><I>osts </I><I>w</I><I>ill
be</I><I> </I><I>in</I><I>c</I><I>urr</I><I>e</I><I>d in </I><I>c</I><I>onn</I><I>ec</I><I>tion </I><I>w</I><I>ith the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion, </I><I>(</I><I>v</I><I>)</I><I> </I><I>the</I><I> </I><I>timing to
</I><I>c</I><I>onsummate</I><I> </I><I>the</I><I> </I><I>propos</I><I>e</I><I>d transa</I><I>c</I><I>tion,</I><I> </I><I>(v</I><I>i) the</I><I> </I><I>possibility</I><I> </I><I>that the</I><I> </I><I>p</I><I>r</I><I>opos</I><I>e</I><I>d
transa</I><I>c</I><I>tion do</I><I>e</I><I>s not </I><I>c</I><I>los</I><I>e</I><I>, in</I><I>c</I><I>luding, but not limit</I><I>e</I><I>d to, due</I><I> </I><I>to the failure</I><I> </I><I>to satisfy</I><I> </I><I>the</I><I>
c</I><I>los</I><I>i</I><I>ng </I><I>c</I><I>onditions, in</I><I>c</I><I>luding </I><I>t</I><I>he</I><I> </I><I>r</I><I>ece</I><I>ipt of r</I><I>e</I><I>quir</I><I>e</I><I>d </I><I>r</I><I>e</I><I>gulatory</I><I> </I><I>appro</I><I>v</I><I>als and
the r</I><I>ece</I><I>ipt of appro</I><I>v</I><I>al of both Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s and </I><I>C</I><I>igna</I><I>&#146;</I><I>s shar</I><I>e</I><I>hold</I><I>e</I><I>rs and sto</I><I>ck</I><I>h</I><I>old</I><I>e</I><I>rs,
r</I><I>e</I><I>sp</I><I>ec</I><I>ti</I><I>ve</I><I>l</I><I>y</I><I>, and </I><I>(v</I><I>iii)</I><I> </I><I>t</I><I>h</I><I>e</I><I> </I><I>ris</I><I>k</I><I>s and un</I><I>ce</I><I>r</I><I>t</I><I>ainti</I><I>e</I><I>s
d</I><I>e</I><I>tail</I><I>e</I><I>d by</I><I> </I><I>C</I><I>igna </I><I>w</I><I>ith r</I><I>e</I><I>sp</I><I>ec</I><I>t to its busin</I><I>e</I><I>ss as d</I><I>e</I><I>s</I><I>c</I><I>rib</I><I>e</I><I>d in its r</I><I>e</I><I>ports and</I>
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>do</I><I>c</I><I>um</I><I>e</I><I>nts fil</I><I>e</I><I>d </I><I>w</I><I>ith the</I><I> </I><I>SE</I><I>C</I><I>. All fo</I><I>r</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing
stat</I><I>e</I><I>m</I><I>e</I><I>nts attributable</I><I> </I><I>to Anth</I><I>e</I><I>m, </I><I>C</I><I>igna or any</I><I> </I><I>p</I><I>e</I><I>rson a</I><I>c</I><I>ting on b</I><I>e</I><I>half of Anth</I><I>e</I><I>m and/or </I><I>C</I><I>igna
are</I><I> ex</I><I>pr</I><I>e</I><I>ssly</I><I> </I><I>qualifi</I><I>e</I><I>d in th</I><I>e</I><I>ir </I><I>e</I><I>ntir</I><I>e</I><I>ty by</I><I> </I><I>this </I><I>c</I><I>autionary</I><I> </I><I>stat</I><I>e</I><I>m</I><I>e</I><I>nt.
R</I><I>e</I><I>ad</I><I>e</I><I>rs are</I><I> </I><I>c</I><I>aution</I><I>e</I><I>d not to pla</I><I>c</I><I>e</I><I> </I><I>undue</I><I> </I><I>r</I><I>e</I><I>l</I><I>ian</I><I>c</I><I>e</I><I> </I><I>on th</I><I>e</I><I>se</I><I>
</I><I>for</I><I>w</I><I>ard-loo</I><I>k</I><I>ing stat</I><I>e</I><I>m</I><I>e</I><I>nts that sp</I><I>e</I><I>ak</I><I> </I><I>only</I><I> </I><I>as of the</I><I> </I><I>date</I><I> </I><I>h</I><I>e</I><I>r</I><I>e</I><I>of.
E</I><I>x</I><I>c</I><I>e</I><I>pt to the</I><I> ex</I><I>t</I><I>e</I><I>n</I><I>t oth</I><I>e</I><I>r</I><I>w</I><I>ise</I><I> </I><I>r</I><I>e</I><I>quir</I><I>e</I><I>d by f</I><I>e</I><I>d</I><I>e</I><I>ral
s</I><I>ec</I><I>uriti</I><I>e</I><I>s la</I><I>w</I><I>, n</I><I>e</I><I>ith</I><I>e</I><I>r Anth</I><I>e</I><I>m nor </I><I>C</I><I>igna und</I><I>e</I><I>rta</I><I>k</I><I>e</I><I> </I><I>any</I><I> </I><I>obligation to r</I><I>e</I><I>publish
r</I><I>ev</I><I>is</I><I>e</I><I>d for</I><I>w</I><I>ard</I><I>-</I><I>loo</I><I>k</I><I>ing stat</I><I>e</I><I>m</I><I>e</I><I>nts to r</I><I>e</I><I>fl</I><I>ec</I><I>t </I><I>eve</I><I>nts or
</I><I>c</I><I>i</I><I>r</I><I>c</I><I>umstan</I><I>ce</I><I>s aft</I><I>e</I><I>r the</I><I> </I><I>da</I><I>t</I><I>e</I><I> </I><I>h</I><I>e</I><I>r</I><I>e</I><I>of or to r</I><I>e</I><I>fl</I><I>ec</I><I>t the
o</I><I>cc</I><I>urr</I><I>e</I><I>n</I><I>c</I><I>e</I><I> </I><I>of unanti</I><I>c</I><I>ipat</I><I>e</I><I>d </I><I>eve</I><I>nts or the</I><I> </I><I>r</I><I>e</I><I>ce</I><I>ipt</I><I> </I><I>of n</I><I>e</I><I>w</I><I> </I><I>information.
R</I><I>e</I><I>ad</I><I>e</I><I>rs are</I><I> </I><I>also urg</I><I>e</I><I>d to </I><I>c</I><I>ar</I><I>e</I><I>fully</I><I> </I><I>r</I><I>ev</I><I>i</I><I>e</I><I>w</I><I> </I><I>and </I><I>c</I><I>o</I><I>n</I><I>sid</I><I>e</I><I>r the</I><I>
v</I><I>arious dis</I><I>c</I><I>losur</I><I>e</I><I>s in Anth</I><I>e</I><I>m</I><I>&#146;</I><I>s and </I><I>C</I><I>igna</I><I>&#146;</I><I>s SEC</I><I> </I><I>r</I><I>e</I><I>ports.</I> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d)&nbsp;&nbsp;Exhibits</B> </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="3%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:79.80pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Description of Exhibit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amendment to the By-Laws of Anthem, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">99.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Press release, dated July 24, 2015 issued by Anthem, Inc. and Cigna Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #bfbfbf">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements
of the Securities Exchange Act of 1934, Anthem, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>ANTHEM, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>By:</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;/s/ Kathleen S. Kiefer</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Kathleen S. Kiefer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: July&nbsp;24, 2015 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #bfbfbf">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="3%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:79.80pt; font-size:10pt; font-family:Times New Roman">Exhibit&nbsp;Number&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Description of Exhibit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amendment to the By-Laws of Anthem, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center">99.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Press release, dated July 24, 2015, issued by Anthem, Inc. and Cigna Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d15785dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Amendment to Anthem, Inc. By-Laws </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution duly adopted by the Board of Directors of Anthem, Inc., an Indiana corporation (the &#147;Corporation&#148;), effective July&nbsp;23,
2015, the By-Laws of the Corporation are amended to add the following Article XI: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Forum for Adjudication of Disputes </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;11.1 Forum</U>. Unless the Corporation consents in writing to the selection of an alternative forum (an &#147;Alternative
Forum Consent&#148;) the sole and exclusive forum for (a)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (b)&nbsp;any action asserting a claim for breach of a fiduciary duty owed by any Director, officer, employee or
agent of the Corporation to the Corporation or the Corporation&#146;s constituents identified in Chapter 35 of the Indiana Business Corporation Law (IC 23-1-35-1(d)), (c)&nbsp;any action asserting a claim arising pursuant to any provision of the
Indiana Business Corporation Law or the Corporation&#146;s Articles of Incorporation or these By-Laws (in each case, as may be amended from time to time), or (d)&nbsp;any action asserting a claim governed by the internal affairs doctrine, shall be,
to the fullest extent permitted by law, the Marion Superior Court (Marion County, Indiana) (or, if the Marion Superior Court lacks jurisdiction, the United States District Court for the Southern District of Indiana); in all cases subject to the
court&#146;s having personal jurisdiction over the indispensable parties named as defendants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;11.2 Personal
Jurisdiction</U>. If any action the subject matter of which is within the scope of Section&nbsp;11.1 of these By-Laws is filed in a court other than the Marion Superior Court (Marion County, Indiana) (or, if the Marion Superior Court lacks
jurisdiction, the United States District Court for the Southern District of Indiana) (a &#147;Foreign Action&#148;) in the name of any shareholder (including any beneficial owner), such shareholder shall be deemed to have consented to (a)&nbsp;the
personal jurisdiction of the Marion Superior Court or the United States District Court for the Southern District of Indiana in connection with any action brought in any such court to enforce Section&nbsp;11.1 of these By-Laws and (b)&nbsp;having
service of process made upon such shareholder in any such action by service upon such shareholder&#146;s counsel in the Foreign Action as agent for such shareholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;11.3 Enforceability</U>. Any person or entity purchasing or otherwise acquiring any interest in shares of stock of the
Corporation shall be deemed to have notice of and consented to the provisions of this Article XI. If any provision of this Article XI shall be held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any
reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provision in any other circumstance and of the remaining provisions of this Article XI (including, without limitation, each portion of
any sentence of this Article XI containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and
circumstances shall not in any way be affected or impaired thereby. The existence of any prior Alternative Forum Consent shall not act as a waiver of the Corporation&#146;s ongoing consent right as set forth above in Section&nbsp;11.1 with respect
to any current or future actions or claims. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d15785dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Filed by Anthem, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">(Commission
File No.&nbsp;001-16751) pursuant </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">to Rule 425 under the Securities Act of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1933 and deemed filed pursuant to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Rule 14a-12 under the Securities Exchange </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Act of 1934 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Subject Company: Cigna
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Commission File No.&nbsp;001-08323 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g15785g54b66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>ANTHEM ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE CIGNA CORPORATION </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>Combination will create the premier health services company with critical diversification to lead the transformation of health care for consumers by enhancing health care access, quality and affordability
</B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>Cigna shareholders receiving consideration of $103.40 per share in cash and 0.5152 shares of Anthem stock in exchange for each Cigna share, reflecting a value of $188.00 based on Anthem&#146;s unaffected share price
as of May&nbsp;28, 2015 </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>Combination expected to drive adjusted earnings per share accretion approaching 10% in year one, with accretion more than doubling in year two </B></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>The combined company will cover approximately 53&nbsp;million medical members with well positioned commercial, government, consumer, specialty businesses along with a market leading international franchise
</B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indianapolis, Ind. and Bloomfield, Conn.</B> &#150; July&nbsp;24, 2015 &#150; Anthem, Inc. (NYSE: ANTM) and Cigna Corporation (NYSE:
CI) today announced that they have entered into a definitive agreement whereby Anthem will acquire all outstanding shares of Cigna in a cash and stock transaction and Cigna shareholders will receive $103.40 in cash and 0.5152 Anthem common shares
for each Cigna common share. The total per share consideration equates to approximately $188.00 for each Cigna share based on Anthem&#146;s closing share price on May&nbsp;28, 2015, valuing the transaction at $54.2 billion on an enterprise basis.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The combined company will be an industry leader with enhanced diversification and capabilities to advance the
transformation of health care delivery for consumers. Following the transaction, Anthem will have more than $115 billion in pro forma annual revenues, based on the most recent 2015 outlooks publicly reported by both companies and will gain
meaningful diversification covering approximately 53&nbsp;million medical members with well positioned commercial, government, consumer, specialty and international franchises. Upon the close of the transaction, Joseph Swedish will serve as Chairman
and Chief Executive Officer of the combined company and David Cordani will be President and Chief Operating Officer. In addition, effective upon closing, the Anthem Board of Directors will be expanded to 14 members. David Cordani and four
independent directors from Cigna&#146;s current Board of Directors will join the nine current members of the Anthem Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreement
provides an &#147;unaffected&#148; premium to Cigna&#146;s shareholders of approximately 38.4%, based on the unaffected closing price of Cigna&#146;s shares on May&nbsp;28, 2015. Under the terms of the transaction, the consideration consists of
approximately 55% cash and 45% Anthem shares, and the combined company would reflect a pro forma equity ownership comprised of approximately 67% Anthem shareholders and approximately 33% Cigna shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are very pleased to announce an agreement that will deliver meaningful value to consumers and shareholders through expanded provider collaboration,
enhanced affordability and cost of care management capabilities, and superior innovations that deliver a high quality health care experience for consumers. We believe that this transaction will allow us to enhance our competitive position and be
better positioned to apply the insights and access of a broad network and dedicated local presence to the health care challenges of the increasingly diverse markets, membership, and communities we serve. The Cigna team has built a set of
capabilities that greatly complement our own offerings and the combined company will have a competitive presence across commercial, government, international and specialty segments. These expanded capabilities will enable us to better serve our
customers as their health care needs evolve,&#148; said Joseph Swedish, President and Chief Executive Officer of Anthem. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our companies share proud
histories and an even brighter future. Going forward our new company will deliver an acceleration of innovative and affordable health and protection benefits solutions that help address our health system&#146;s challenges and provide supplemental
insurance protection, and health care security to consumers, their families, and the communities we share with them. The complementary nature of our businesses will allow us to leverage the deep global health care knowledge, local market talent, and
expertise of both organizations to ensure that consumers have access to affordable and personalized solutions across diverse life and health stages and position us for sustained success,&#148; said David M. Cordani, President and Chief Executive
Officer of Cigna. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilizing Anthem&#146;s and Cigna&#146;s complementary strengths, the combined company will be able to deliver higher quality health
care as America&#146;s valued health partner. By combining Anthem&#146;s Blue Cross and Blue Shield footprint in 14 states and Medicaid footprint via its Amerigroup brand in 19 states with Cigna&#146;s broad portfolio of health and protection
services in the U.S. and globally, the combined company will offer a comprehensive range of high quality, high value products and services to the full spectrum of customers &#150; individuals, employers and State and Federal governments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is expected to close in the second half of 2016, pending the receipt of customary approvals, including certain state regulatory approvals and
expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. In addition, the transaction is subject to customary closing conditions, including the approval of Cigna&#146;s shareholders of the merger agreement and
Anthem&#146;s shareholders of the issuance of shares in the transaction. Anthem is confident in its ability to obtain all necessary regulatory and other approvals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The combined company expects to achieve adjusted earnings per share accretion approaching 10% in year one, with
the accretion more than doubling by year two following the closing of the transaction. We are confident in our ability to achieve synergy targets and are committed to retaining investment grade debt ratings. Anthem expects its debt-to-capital ratio
to be approximately 49% at the time of close, with a plan to bring the ratio down to the low 40% range within 24 months. Anthem has received committed financing from Bank of America, Credit Suisse and UBS Investment Bank in connection with the
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem and Cigna management will host a conference call to discuss the transaction at 8:30 AM EDT today, July&nbsp;24, 2015. Additional
materials regarding the transaction are available on our website at <U>www.betterhealthcaretogether.com/</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem&#146;s lead financial advisor is UBS
Investment Bank and Credit Suisse also served as financial advisor and its legal advisor is White&nbsp;&amp; Case LLP. Morgan Stanley is acting as Cigna&#146;s financial advisor, and Cravath, Swaine&nbsp;&amp; Moore LLP is acting as legal advisor to
Cigna. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem and Cigna will hold a conference call and webcast at 8:30 a.m. Eastern Daylight Time (&#147;EDT&#148;) today, July&nbsp;24, 2015, to discuss the
transaction. The conference call should be accessed at least 15 minutes prior to its start with the following numbers. An investor presentation is available for download at <U>www.antheminc.com</U> or <U>www.cigna.com/aboutcigna/investors</U> under
the &#147;Investors&#148; link. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>877-871-3172 (Domestic)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" NOWRAP>877-344-7529&nbsp;(Domestic&nbsp;Replay)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>412-902-6603 (International)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" NOWRAP>412-317-0088&nbsp;(International&nbsp;Replay)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The access code for the July&nbsp;24, 2015, conference call is 4135855. The access code for the replay is 10069758. The replay
will be available from 1:00 p.m. EDT on July&nbsp;24, 2015, until the end of the day on August&nbsp;7, 2015. A webcast replay will be available following the call. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Anthem Contacts:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B><U>Investor Relations</U></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B><U>Media</U></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Doug Simpson, 317-488-6181</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B>Kristin Binns, 917-697-7802</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Douglas.simpson@anthem.com</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B>Kristin.binns@anthem.com</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cigna Contacts:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B><U>Investor Relations</U></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B><U>Media</U></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Will McDowell, 215-761-4198</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B>Matt Asensio, 860-226-2599</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>William.mcdowell2@cigna.com</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP><B>Matthew.asensio@cigna.com</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Anthem, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their
members access to the care they need. With nearly 71&nbsp;million people served by its affiliated companies, including more than 38&nbsp;million enrolled in its family of health plans, Anthem is one of the nation&#146;s leading health benefits
companies. For more information about Anthem&#146;s family of companies, please visit <U>www.antheminc.com/companies</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Cigna </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cigna Corporation (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All
products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Connecticut General Life Insurance Company, Cigna Health and Life Insurance Company, Life Insurance Company of North America and
Cigna Life Insurance Company of New York. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group
life, accident and disability insurance. Cigna maintains sales capability in 30 countries and jurisdictions, and has more than 88&nbsp;million customer relationships throughout the world. To learn more about Cigna<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, including links to follow us on Facebook or Twitter, visit www.cigna.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Information for Investors and Shareholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication does not constitute an offer to sell or a solicitation of an offer to sell or a solicitation of an offer to buy any securities or a
solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section&nbsp;10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed transaction between Anthem, Inc. (&#147;Anthem&#148;) and Cigna Corporation (&#147;Cigna&#148;) will be submitted to Anthem&#146;s and
Cigna&#146;s shareholders and stockholders (as applicable) for their consideration. In connection with the transaction, Anthem and Cigna will file relevant materials with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;), including
an Anthem registration statement on Form S-4 that will include a joint proxy statement of Anthem and Cigna that also constitutes a prospectus of Anthem, and each will mail the definitive joint proxy statement/prospectus to its shareholders and
stockholders, respectively. This communication is not a substitute for the registration statement, joint proxy statement/prospectus or any other document that Anthem and/or Cigna may file with the SEC in connection with the proposed transaction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INVESTORS AND SECURITY HOLDERS OF ANTHEM AND CIGNA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC
CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of the registration statement containing the joint
proxy statement/prospectus and other documents filed with the SEC by Anthem or Cigna (when available) through the web site maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Anthem will be available free of
charge on Anthem&#146;s internet website at http://www.antheminc.com or by contacting Anthem&#146;s Investor Relations Department at (317)&nbsp;488-6168. Copies of the documents filed with the SEC by Cigna will be available free of charge on
Cigna&#146;s internet website at http://www.cigna.com or by contacting Cigna&#146;s Investor Relations Department at (215)&nbsp;761-4198. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anthem, Cigna
and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. You can find information about Anthem&#146;s
executive officers and directors in Anthem&#146;s annual report on Form 10-K for the year ended December&nbsp;31, 2014 and its definitive proxy statement filed with the SEC on April&nbsp;1, 2015. You can find information about Cigna&#146;s executive
officers and directors in Cigna&#146;s annual report on Form 10-K for the year ended December&nbsp;31, 2014 and its definitive proxy statement filed with the SEC on March&nbsp;13, 2015. Additional information regarding the interests of such
potential participants will be included in the joint proxy statement/prospectus when it is filed with the SEC. You may obtain free copies of these documents using the sources indicated above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>LITIGATION REFORM ACT OF 1995 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This
document, and oral statements made with respect to information contained in this communication, contain certain forward-looking information about Anthem, Inc. (&#147;Anthem&#148;), Cigna Corporation (&#147;Cigna&#148;) and the combined businesses of
Anthem and Cigna that is intended to be covered by the safe harbor for &#147;forward-looking statements&#148; provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not generally
historical facts. Words such as &#147;expect(s),&#148; &#147;feel(s),&#148; &#147;believe(s),&#148; &#147;will,&#148; &#147;may,&#148; &#147;anticipate(s),&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;project&#148; and similar expressions
(including the negative thereof) are intended to identify forward-looking statements, which generally are not historical in nature. These statements include, but are not limited to, statements regarding the merger between Anthem and Cigna;
Anthem&#146;s financing of the proposed transaction; the combined company&#146;s expected future performance (including expected results of operations and financial guidance); the combined company&#146;s future financial condition, operating
results, strategy and plans; statements about regulatory and other approvals; synergies from the proposed transaction; the combined company&#146;s expected debt-to-capital ratio and ability to retain investment grade ratings; the closing date for
the proposed transaction; financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future
performance. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond Anthem&#146;s and Cigna&#146;s control, that could cause actual results and other future
events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in Anthem&#146;s and Cigna&#146;s public filings
with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;); those relating to the proposed transaction, as detailed from time to time in Anthem&#146;s and Cigna&#146;s filings with the SEC; increased government participation in, or
regulation or taxation of health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, or Health Care Reform;
trends in health care costs and utilization rates; our ability to secure sufficient premium rates including regulatory approval for and implementation of such rates; our participation in the federal and state health insurance exchanges under Health
Care Reform, which have experienced and continue to experience challenges due to implementation of initial and phased-in provisions of Health Care Reform, and which entail uncertainties associated with the mix and volume of business, particularly in
Individual and Small Group markets, that could negatively impact the adequacy of our premium rates and which may not be sufficiently offset by the risk apportionment provisions of Health Care Reform; our ability to contract with providers consistent
with past practice; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding Medicare and Medicaid programs, including those
related to non-compliance with the complex regulations imposed thereon and funding risks with respect to revenue received from participation therein; our projected consolidated revenue growth and global medical customer growth; a downgrade in our
financial strength ratings; litigation and investigations targeted at our industry and our ability to resolve litigation and investigations within estimates; medical malpractice or professional liability claims or other risks related to health care
services provided by our subsidiaries; our ability to repurchase shares of its common stock and pay dividends on its common stock due to the adequacy of its cash flow and earnings and other considerations; non- compliance by any party with the
Express Scripts, Inc. pharmacy benefit management services agreement, which could result in financial penalties; our inability to meet customer demands, and sanctions imposed by governmental entities, including the
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
Centers for Medicare and Medicaid Services; events that result in negative publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems
and e-business organization and to maintain good relationships with third party vendors for information system resources; events that may negatively affect Anthem&#146;s licenses with the Blue Cross and Blue Shield Association; possible impairment
of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member or employee sensitive or confidential
information, including the impact and outcome of investigations, inquiries, claims and litigation related to the cyber attack Anthem reported in February 2015; changes in the economic and market conditions, as well as regulations that may negatively
affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding
indebtedness; general risks associated with mergers and acquisitions; various laws and provisions in Anthem&#146;s governing documents that may prevent or discourage takeovers and business combinations; future public health epidemics and
catastrophes; and general economic downturns. Important factors that could cause actual results and other future events to differ materially from the forward-looking statements made in this communication are set forth in other reports or documents
that Anthem and/or Cigna may file from time to time with the SEC, and include, but are not limited to: (i)&nbsp;the ultimate outcome of the proposed transaction, including the ability to achieve the synergies and value creation contemplated by the
proposed transaction, (ii)&nbsp;the ultimate outcome and results of integrating the operations of Anthem and Cigna, (iii)&nbsp;disruption from the merger making it more difficult to maintain businesses and operational relationships, (iv)&nbsp;the
risk that unexpected costs will be incurred in connection with the proposed transaction, (v)&nbsp;the timing to consummate the proposed transaction, (vi)&nbsp;the possibility that the proposed transaction does not close, including, but not limited
to, due to the failure to satisfy the closing conditions, including the receipt of required regulatory approvals and the receipt of approval of both Anthem&#146;s and Cigna&#146;s shareholders and stockholders, respectively, and (viii)&nbsp;the
risks and uncertainties detailed by Cigna with respect to its business as described in its reports and documents filed with the SEC. All forward-looking statements attributable to Anthem, Cigna or any person acting on behalf of Anthem and/or Cigna
are expressly qualified in their entirety by this cautionary statement. Readers are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal
securities law, neither Anthem nor Cigna undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events or the receipt of new
information. Readers are also urged to carefully review and consider the various disclosures in Anthem&#146;s and Cigna&#146;s SEC reports. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g15785g54b66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g15785g54b66.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@,"
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`)4#&@,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/$OVZ-&TC5OVQ/C[+JNE:;J<MMK7P]M;>34+&UO9+>V'P2^
M%UP+:%[F)S%`+BYN)?+4A=\\C8W.Q/Z1P=@<#BLLKU,3@Z&(G'%3BI5:5.I)
M15*BU%.<6TDVW;:[;ZGQ'$N+Q6'QU*%#$U:$'0BW&G4G!7]I55[1:5[)*^]D
MNQ\J?\(CX4_Z%CP]_P""73?_`)&KZS^R,I_Z%>$_\)J/_P`@?/?VCF'_`$'X
MC_P?5_\`D@_X1'PI_P!"QX>_\$NF_P#R-1_9&4_]"O"?^$U'_P"0#^T<P_Z#
M\1_X/J__`"0?\(CX4_Z%CP]_X)=-_P#D:C^R,I_Z%>$_\)J/_P`@']HYA_T'
MXC_P?5_^2#_A$?"G_0L>'O\`P2Z;_P#(U']D93_T*\)_X34?_D`_M',/^@_$
M?^#ZO_R0?\(CX4_Z%CP]_P""73?_`)&H_LC*?^A7A/\`PFH__(!_:.8?]!^(
M_P#!]7_Y(/\`A$?"G_0L>'O_``2Z;_\`(U']D93_`-"O"?\`A-1_^0#^T<P_
MZ#\1_P"#ZO\`\D'_``B/A3_H6/#W_@ETW_Y&H_LC*?\`H5X3_P`)J/\`\@']
MHYA_T'XC_P`'U?\`Y(/^$1\*?]"QX>_\$NF__(U']D93_P!"O"?^$U'_`.0#
M^T<P_P"@_$?^#ZO_`,D'_"(^%/\`H6/#W_@ETW_Y&H_LC*?^A7A/_":C_P#(
M!_:.8?\`0?B/_!]7_P"2#_A$?"G_`$+'A[_P2Z;_`/(U']D93_T*\)_X34?_
M`)`/[1S#_H/Q'_@^K_\`)!_PB/A3_H6/#W_@ETW_`.1J/[(RG_H5X3_PFH__
M`"`?VCF'_0?B/_!]7_Y(/^$1\*?]"QX>_P#!+IO_`,C4?V1E/_0KPG_A-1_^
M0#^T<P_Z#\1_X/J__)!_PB/A3_H6/#W_`()=-_\`D:C^R,I_Z%>$_P#":C_\
M@']HYA_T'XC_`,'U?_D@_P"$1\*?]"QX>_\`!+IO_P`C4?V1E/\`T*\)_P"$
MU'_Y`/[1S#_H/Q'_`(/J_P#R0?\`"(^%/^A8\/?^"73?_D:C^R,I_P"A7A/_
M``FH_P#R`?VCF'_0?B/_``?5_P#D@_X1'PI_T+'A[_P2Z;_\C4?V1E/_`$*\
M)_X34?\`Y`/[1S#_`*#\1_X/J_\`R0?\(CX4_P"A8\/?^"73?_D:C^R,I_Z%
M>$_\)J/_`,@']HYA_P!!^(_\'U?_`)(/^$1\*?\`0L>'O_!+IO\`\C4?V1E/
M_0KPG_A-1_\`D`_M',/^@_$?^#ZO_P`D'_"(^%/^A8\/?^"73?\`Y&H_LC*?
M^A7A/_":C_\`(!_:.8?]!^(_\'U?_D@_X1'PI_T+'A[_`,$NF_\`R-1_9&4_
M]"O"?^$U'_Y`/[1S#_H/Q'_@^K_\D'_"(^%/^A8\/?\`@ETW_P"1J/[(RG_H
M5X3_`,)J/_R`?VCF'_0?B/\`P?5_^2#_`(1'PI_T+'A[_P`$NF__`"-1_9&4
M_P#0KPG_`(34?_D`_M',/^@_$?\`@^K_`/)!_P`(CX4_Z%CP]_X)=-_^1J/[
M(RG_`*%>$_\`":C_`/(!_:.8?]!^(_\`!]7_`.2#_A$?"G_0L>'O_!+IO_R-
M1_9&4_\`0KPG_A-1_P#D`_M',/\`H/Q'_@^K_P#)!_PB/A3_`*%CP]_X)=-_
M^1J/[(RG_H5X3_PFH_\`R`?VCF'_`$'XC_P?5_\`D@_X1'PI_P!"QX>_\$NF
M_P#R-1_9&4_]"O"?^$U'_P"0#^T<P_Z#\1_X/J__`"0?\(CX4_Z%CP]_X)=-
M_P#D:C^R,I_Z%>$_\)J/_P`@']HYA_T'XC_P?5_^2#_A$?"G_0L>'O\`P2Z;
M_P#(U']D93_T*\)_X34?_D`_M',/^@_$?^#ZO_R0?\(CX4_Z%CP]_P""73?_
M`)&H_LC*?^A7A/\`PFH__(!_:.8?]!^(_P#!]7_Y(/\`A$?"G_0L>'O_``2Z
M;_\`(U']D93_`-"O"?\`A-1_^0#^T<P_Z#\1_P"#ZO\`\D'_``B/A3_H6/#W
M_@ETW_Y&H_LC*?\`H5X3_P`)J/\`\@']HYA_T'XC_P`'U?\`Y(/^$1\*?]"Q
MX>_\$NF__(U']D93_P!"O"?^$U'_`.0#^T<P_P"@_$?^#ZO_`,D'_"(^%/\`
MH6/#W_@ETW_Y&H_LC*?^A7A/_":C_P#(!_:.8?\`0?B/_!]7_P"2#_A$?"G_
M`$+'A[_P2Z;_`/(U']D93_T*\)_X34?_`)`/[1S#_H/Q'_@^K_\`)!_PB/A3
M_H6/#W_@ETW_`.1J/[(RG_H5X3_PFH__`"`?VCF'_0?B/_!]7_Y(/^$1\*?]
M"QX>_P#!+IO_`,C4?V1E/_0KPG_A-1_^0#^T<P_Z#\1_X/J__)!_PB/A3_H6
M/#W_`()=-_\`D:C^R,I_Z%>$_P#":C_\@']HYA_T'XC_`,'U?_D@_P"$1\*?
M]"QX>_\`!+IO_P`C4?V1E/\`T*\)_P"$U'_Y`/[1S#_H/Q'_`(/J_P#R0?\`
M"(^%/^A8\/?^"73?_D:C^R,I_P"A7A/_``FH_P#R`?VCF'_0?B/_``?5_P#D
M@_X1'PI_T+'A[_P2Z;_\C4?V1E/_`$*\)_X34?\`Y`/[1S#_`*#\1_X/J_\`
MR0?\(CX4_P"A8\/?^"73?_D:C^R,I_Z%>$_\)J/_`,@']HYA_P!!^(_\'U?_
M`)(/^$1\*?\`0L>'O_!+IO\`\C4?V1E/_0KPG_A-1_\`D`_M',/^@_$?^#ZO
M_P`D'_"(^%/^A8\/?^"73?\`Y&H_LC*?^A7A/_":C_\`(!_:.8?]!^(_\'U?
M_D@_X1'PI_T+'A[_`,$NF_\`R-1_9&4_]"O"?^$U'_Y`/[1S#_H/Q'_@^K_\
MD'_"(^%/^A8\/?\`@ETW_P"1J/[(RG_H5X3_`,)J/_R`?VCF'_0?B/\`P?5_
M^2#_`(1'PI_T+'A[_P`$NF__`"-1_9&4_P#0KPG_`(34?_D`_M',/^@_$?\`
M@^K_`/)!_P`(CX4_Z%CP]_X)=-_^1J/[(RG_`*%>$_\`":C_`/(!_:.8?]!^
M(_\`!]7_`.2#_A$?"G_0L>'O_!+IO_R-1_9&4_\`0KPG_A-1_P#D`_M',/\`
MH/Q'_@^K_P#)!_PB/A3_`*%CP]_X)=-_^1J/[(RG_H5X3_PFH_\`R`?VCF'_
M`$'XC_P?5_\`D@_X1'PI_P!"QX>_\$NF_P#R-1_9&4_]"O"?^$U'_P"0#^T<
MP_Z#\1_X/J__`"0?\(CX4_Z%CP]_X)=-_P#D:C^R,I_Z%>$_\)J/_P`@']HY
MA_T'XC_P?5_^2#_A$?"G_0L>'O\`P2Z;_P#(U']D93_T*\)_X34?_D`_M',/
M^@_$?^#ZO_R0?\(CX4_Z%CP]_P""73?_`)&H_LC*?^A7A/\`PFH__(!_:.8?
M]!^(_P#!]7_Y(/\`A$?"G_0L>'O_``2Z;_\`(U']D93_`-"O"?\`A-1_^0#^
MT<P_Z#\1_P"#ZO\`\D'_``B/A3_H6/#W_@ETW_Y&H_LC*?\`H5X3_P`)J/\`
M\@']HYA_T'XC_P`'U?\`Y(/^$1\*?]"QX>_\$NF__(U']D93_P!"O"?^$U'_
M`.0#^T<P_P"@_$?^#ZO_`,D'_"(^%/\`H6/#W_@ETW_Y&H_LC*?^A7A/_":C
M_P#(!_:.8?\`0?B/_!]7_P"2#_A$?"G_`$+'A[_P2Z;_`/(U']D93_T*\)_X
M34?_`)`/[1S#_H/Q'_@^K_\`)!_PB/A3_H6/#W_@ETW_`.1J/[(RG_H5X3_P
MFH__`"`?VCF'_0?B/_!]7_Y(/^$1\*?]"QX>_P#!+IO_`,C4?V1E/_0KPG_A
M-1_^0#^T<P_Z#\1_X/J__)!_PB/A3_H6/#W_`()=-_\`D:C^R,I_Z%>$_P#"
M:C_\@']HYA_T'XC_`,'U?_D@_P"$1\*?]"QX>_\`!+IO_P`C4?V1E/\`T*\)
M_P"$U'_Y`/[1S#_H/Q'_`(/J_P#R0?\`"(^%/^A8\/?^"73?_D:C^R,I_P"A
M7A/_``FH_P#R`?VCF'_0?B/_``?5_P#D@_X1'PI_T+'A[_P2Z;_\C4?V1E/_
M`$*\)_X34?\`Y`/[1S#_`*#\1_X/J_\`R0?\(CX4_P"A8\/?^"73?_D:C^R,
MI_Z%>$_\)J/_`,@']HYA_P!!^(_\'U?_`)(/^$1\*?\`0L>'O_!+IO\`\C4?
MV1E/_0KPG_A-1_\`D`_M',/^@_$?^#ZO_P`D'_"(^%/^A8\/?^"73?\`Y&H_
MLC*?^A7A/_":C_\`(!_:.8?]!^(_\'U?_D@_X1'PI_T+'A[_`,$NF_\`R-1_
M9&4_]"O"?^$U'_Y`/[1S#_H/Q'_@^K_\D'_"(^%/^A8\/?\`@ETW_P"1J/[(
MRG_H5X3_`,)J/_R`?VCF'_0?B/\`P?5_^2#_`(1'PI_T+'A[_P`$NF__`"-1
M_9&4_P#0KPG_`(34?_D`_M',/^@_$?\`@^K_`/)!_P`(CX4_Z%CP]_X)=-_^
M1J/[(RG_`*%>$_\`":C_`/(!_:.8?]!^(_\`!]7_`.2#_A$?"G_0L>'O_!+I
MO_R-1_9&4_\`0KPG_A-1_P#D`_M',/\`H/Q'_@^K_P#)!_PB/A3_`*%CP]_X
M)=-_^1J/[(RG_H5X3_PFH_\`R`?VCF'_`$'XC_P?5_\`D@_X1'PI_P!"QX>_
M\$NF_P#R-1_9&4_]"O"?^$U'_P"0#^T<P_Z#\1_X/J__`"0?\(CX4_Z%CP]_
MX)=-_P#D:C^R,I_Z%>$_\)J/_P`@']HYA_T'XC_P?5_^2#_A$?"G_0L>'O\`
MP2Z;_P#(U']D93_T*\)_X34?_D`_M',/^@_$?^#ZO_R0?\(CX4_Z%CP]_P""
M73?_`)&H_LC*?^A7A/\`PFH__(!_:.8?]!^(_P#!]7_Y(/\`A$?"G_0L>'O_
M``2Z;_\`(U']D93_`-"O"?\`A-1_^0#^T<P_Z#\1_P"#ZO\`\D'_``B/A3_H
M6/#W_@ETW_Y&H_LC*?\`H5X3_P`)J/\`\@']HYA_T'XC_P`'U?\`Y(/^$1\*
M?]"QX>_\$NF__(U']D93_P!"O"?^$U'_`.0#^T<P_P"@_$?^#ZO_`,D'_"(^
M%/\`H6/#W_@ETW_Y&H_LC*?^A7A/_":C_P#(!_:.8?\`0?B/_!]7_P"2#_A$
M?"G_`$+'A[_P2Z;_`/(U']D93_T*\)_X34?_`)`/[1S#_H/Q'_@^K_\`)!_P
MB/A3_H6/#W_@ETW_`.1J/[(RG_H5X3_PFH__`"`?VCF'_0?B/_!]7_Y(/^$1
M\*?]"QX>_P#!+IO_`,C4?V1E/_0KPG_A-1_^0#^T<P_Z#\1_X/J__)!_PB/A
M3_H6/#W_`()=-_\`D:C^R,I_Z%>$_P#":C_\@']HYA_T'XC_`,'U?_D@_P"$
M1\*?]"QX>_\`!+IO_P`C4?V1E/\`T*\)_P"$U'_Y`/[1S#_H/Q'_`(/J_P#R
M0?\`"(^%/^A8\/?^"73?_D:C^R,I_P"A7A/_``FH_P#R`?VCF'_0?B/_``?5
M_P#D@_X1'PI_T+'A[_P2Z;_\C4?V1E/_`$*\)_X34?\`Y`/[1S#_`*#\1_X/
MJ_\`R0?\(CX4_P"A8\/?^"73?_D:C^R,I_Z%>$_\)J/_`,@']HYA_P!!^(_\
M'U?_`)(/^$1\*?\`0L>'O_!+IO\`\C4?V1E/_0KPG_A-1_\`D`_M',/^@_$?
M^#ZO_P`D'_"(^%/^A8\/?^"73?\`Y&H_LC*?^A7A/_":C_\`(!_:.8?]!^(_
M\'U?_D@_X1'PI_T+'A[_`,$NF_\`R-1_9&4_]"O"?^$U'_Y`/[1S#_H/Q'_@
M^K_\D'_"(^%/^A8\/?\`@ETW_P"1J/[(RG_H5X3_`,)J/_R`?VCF'_0?B/\`
MP?5_^2#_`(1'PI_T+'A[_P`$NF__`"-1_9&4_P#0KPG_`(34?_D`_M',/^@_
M$?\`@^K_`/)!_P`(CX4_Z%CP]_X)=-_^1J/[(RG_`*%>$_\`":C_`/(!_:.8
M?]!^(_\`!]7_`.2#_A$?"G_0L>'O_!+IO_R-1_9&4_\`0KPG_A-1_P#D`_M'
M,/\`H/Q'_@^K_P#)!_PB/A3_`*%CP]_X)=-_^1J/[(RG_H5X3_PFH_\`R`?V
MCF'_`$'XC_P?5_\`D@_X1'PI_P!"QX>_\$NF_P#R-1_9&4_]"O"?^$U'_P"0
M#^T<P_Z#\1_X/J__`"1\D^)-7U:Q\1:]966J:C9V=GK6J6MI:6M[<V]M:VUO
M?3Q06UM!%*J0011(B)&BJJJH50``*_&<TA"EF>8TZ<53IT\5B(QC%*,8QC5F
MHQC%645%))))))61^FX"4IX'!3G)RG*A1<I-MMMTXMMMZMMZMO5L_7/]MC_D
M\#]H/_L8?A[_`.J+^%%?HO!'_(IQ'_874_\`3-`^+XJ_Y&%'_L'A_P"G:Q\R
M5]B?,A0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`'Z2:-^P1X-?X:^`/B1XT_:6\,_#K3_'GAGPSKUK#XH\+Z5IMG;7G
MB+0;;7AHMOJVK?$:PCU*Y@@FE7<D432+;/+Y*#*K\94XKQ*QN+P6%R6IBYX2
MI4IMTJLI-JG4=/G<(8>;BFTNK2;2NSZ>'#U#ZKAL37S2&%C7A":52G&*3G!3
MY5*5:*DTGV5[7LCSC]H;]BG7?@AX)L?B1H'CG2_B5X)DN+6WU/5M/TQ-%ETP
M:C+';Z7>QP1ZWJD&HZ9<7<BV_GP7>Y)9H!Y3)*SQ=N3\2TLRQ,L%5PLL%B8I
MN$)2YU+E3<HWY*;C**5[..J3UNK/FS+(JF`H1Q5+$1Q5"Z4I1CR\M](NRE-2
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M9\OL_9_].ZG-S>T\K6ZWT]G*,I_M/ZQ_M'U=8?D^QSWY^?\`OPY>7D\[WZ6U
M]@_X8L^`G_1\_P`(?^_/@S_Y[U>=_K+FW_1+8O[ZW_S(=O\`8>7_`/0_P_W4
MO_F@^`/$VE6>A>)/$&B:=JUMK^GZ/KFK:58Z[9"(6>M6>GW]Q:6VK6@@N;B,
M6UY!"EQ'Y=Q.NV9=LL@PS?64)RJT:-6=-T9U(0E*G*]X.44W!W47>+=G=)W6
MRV/G:L(TJM2G&:G&G*45);246TI*S:LTKJS?JSU[]GK]G[Q7^T1XTG\*>'+J
MWT>RTO37U;7O$5_;75QI^DV8FCMK>+9;@"XU&ZN)<06IEA:1+>ZD#;+60KY^
M;YOA\GPRKUHNI*4N2G3BTI2=FWOM&*7O2L[-Q6\D=F6Y=6S&NZ-)J$8QYIS:
M;45>RVWDWLKJ]F^C/L1O^"<FEZN/$&E>`?VD/`_C'QGX=MP^H>%DT6SM9;"Z
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M,WP6#JXW$4\-1TE*]V[VC%*[E*VR6R[MI;M'WTO_``3@\/3:O-X1L_VFO!MS
MX_@L'OY?!:^&[(:O##'A7GFLHO'LNHQ6"RLBM<G3<+NY7.%/R?\`KE6C36(E
MDE:.$<N55O:2Y+]$FZ"@Y6^SS_,^B_U9I\[HQS6F\1%7]ER+FLNME5<DO/E/
MSM^(WP^\2_"OQMXA^'_BZV@M?$'AF]6TODM9UN;2:.>V@OK"^LYPJF6RO-.N
MK2[A,B12>5=()8XI`T:?88/%T,=A:.+PS<J-97C=6:LW&46NCC).+LVKIV;5
MF_FL3AJN#KU,-62C4HNS2=ULG%I]I1::V=GJD]#BJZ3`*`"@`H`Z_P"'OA3_
M`(3OQ]X'\#_;_P"RO^$R\7^&O"G]J?9?MW]F_P#"0ZS9:1]O^Q?:+?[9]G^V
M>;Y'GP>9Y>SS$W;EY\77^J83%8KDY_JU&I5Y;\O-[.$I\O-9\M[6O9VWL]C;
M#4?K&(H8?FY/;U(4^:U^7GDHWM=7M>]KJ_='Z&>)?^"?_P`+_!>HKH_C#]L#
MP#X3U9K:*]32_$OA_P`/:%J+6<SRQPW:V6J?%6"8VSR03*LH3:QA<`DH<?(4
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MQBDYP4^52E6BI-)]E>U[(\G^,/[,_P`)OAOX"U7Q;X5_:G^'?Q/UK3[C3(;;
MP;X?C\-+JFHI?:C;65Q-`=.^(FJSA+6">2Y?98RC9`VXHN77OR[.\PQF+IX>
MOD6(P%*2DW6J>TY8\L6TGS8>FO>:Y5[RU?78X\;E>#PF'G6HYM1Q4XN*5*')
MS.[2;7+6F_=3N_=>W0^,Z^D/$/K*X_9=^S_LK6'[3/\`PG.[[;=/:_\`"$_\
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MY\+O`&I_%+XA^#_A[I#F"]\5Z[9:4;P0I<#3;)W\W5-6>V>X@%S%I^F17EZ\
M(FC:1+1D1@S"N7'8N&`P>(Q=17CAX.7+>W,UI&%[.SE)J*=G9N[T.C"8>>+Q
M-##0T=:2C>U^5?:E:ZORQ3DU=7M8^GOVH_V,M1_9M\,>&O%D7CR'QOI.MZ[+
MX=O=WAE_#5QI>HR:?/J6E^4@U[54OH;FVT[5][-):M"UI$%683L;?P\BXDAG
M->MA_JCPM2E!5(_O/:*45)1E]BGRN+E"VDKW>JLK^KFV1RRRE2K+$*O"<^1^
MY[-Q=G*/VYW3497U5K+>^GQ+7TQX1[S^SU^S]XK_`&B/&D_A3PY=6^CV6EZ:
M^K:]XBO[:ZN-/TFS$T=M;Q;+<`7&HW5Q+B"U,L+2);W4@;9:R%?*S?-\/D^&
M5>M%U)2ER4Z<6E*3LV]]HQ2]Z5G9N*WDCT,MRZMF-=T:34(QCS3FTVHJ]EMO
M)O975[-]&?8C?\$Y-+U<>(-*\`_M(>!_&/C/P[;A]0\+)HMG:RV%U(K?9;;6
MYM*\::O=Z)'-(C(LL^FMT)"'!`^=7&-2E[&>*R:MAL-6?NU>=M-+=P4J-.,[
M+HI_,]O_`%9A/VD,-F=*O7I+6GRI6?12<:LW&_=Q^1^:VN:)JGAG6]8\.:Y:
M/I^M>']5U#1-7L)'BDDL=4TJ[FL=0M))()'C=X;N"6,M&[H2A*L003]I2JTZ
MU*G6I2YJ56,9PDKJ\9)2B[.S5TT]4F?+U*<Z-2=*I'EG2DXRCVE%V:TTT:MH
M>E?`;X5?\+M^*_A7X8?V]_PC'_"3?VY_Q//[+_MK[#_8OAO6/$/_`"#?[1L/
MM/G?V3]G_P"/J+9]H\SY]FQ^+-<?_9F`KX[V7M_8<GN<W)?GJ0I_%RSM;GO\
M+O:VE[KJR_"?7L91PGM/8^UYO>Y>:W)"4_AYHWORVW5KWZ6/M'6_V#_@_P"&
M=4N]"\1_MG?#;P]K6GO''?Z/K>D>%])U2Q>2&.XB2[T^_P#BQ%/;.T$L4BB2
M-24E1A\K`GYJEQ5F-:G&K1X;Q-6E+X9PG5E%V=G:4<*T[--:/=6/<GP_@J,W
M3JYY0I3CO&4:<9+JKQ>(36FNJ/C+XX?#;PI\*O&4/AGP=\4/#WQ;TF30['5'
M\4^&ETU-.AO+JYOH)M)8:7XAUF'[3;QVD,K9NPV+Q,Q*,%_I,KQN(QV&=;$X
M&IE]2,Y15*IS<UDHM3]ZG3=G=I>[;1ZOIX>/PM'!UU2H8N&+ARJ7M(<O+=MI
MQ]V<U=63WZ['CM>B<04`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`?"WB[_D:_$_\`V,.M?^G*YK\,S?\`Y&V9_P#8
M7B?_`$],_6,M_P"1?@/^P>A_Z:B?L)^VQ_R>!^T'_P!C#\/?_5%_"BOT+@C_
M`)%.(_["ZG_IF@?&\5?\C"C_`-@\/_3M8^9*^Q/F0H`*`"@`H`*`"@`H`*`"
M@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#]UOB-\`/&7[0W[)'
M[-/A?P5J7AG2]0T7P?\`#'7[J;Q1>:K96;V:?#.+3C%;R:3HVI2-<^=?0MM>
M)%VJYWY`5ORW!YMALGX@SJOB85)PJ5L332I1BW?ZRY:J<X*UHO9MWMH??XG+
MJ^8Y/E=*A*$)4Z=";=1R2M[!1TY8R=[OLO4\V_:&TGP]^SI^Q+:_L]ZQXPTS
MQ'XUUK4K1;""T4V\[*/'\7CC4KR#37N)IK/2K2*$V7VF4H)IKA2%1IS$G;D]
M2MG'$TLWI8:5#"THOF;U7\!T(IRLDY2;YN57LEU2N^7,H4\LR*.6SK1J5Y25
MDM'_`!O:R:C=M1BERW>[?2]C\<J_13XH_;+X7^!/#OQ(_P""=?@WPCXJ^(&B
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M)C<3A<0LRE*-TJ?*H_NU)J*Y9U+N[=]6[:1BWO\`@]7ZH?GQ^MG_``2[6W?3
MOVATNY'AM&LOARMU+&"7BMV@^)`FD0!'^=8BQ`"-R/NGH?S_`(YNIY/RJ\D\
M19>=\/;L?8\*6Y<ROHK4;^EJUSRJ3X;?\$V5CD,7[0/Q=:148QJ=%U4`N%.P
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M)K5Q3:?,EULXJZWM>UW9/]`;'X0?LG_%_P`?P_$KX%_M!7W@/XJZSKFH^(=$
MM+?6+(W9\6RWM]J-W?)X'\8VEGKEX)+F2Y:;3X[I+6XM$98XQ;R.\GR4LPS_
M`"["/!9IE$<5@*4(TYMPE;V2C&*C[>BY4HV25IN+E&>[YDDOHXX+)\;B%BLO
MS%X?&2E*<$I*_M+N3?LJBC4>M[Q3Y7'96>OP)^V!X6^*GA#XPS:9\7/%\/CO
M7Y/#NDW>D^*8=/L]*&I^&WN-1M[`RZ?96\26DT5[;:E"T;&9@8?]:Z%<?6<.
MU\!B,N4\OP[PE%5)*=)R<N6HE%RM*3;:<7%IZ;[)W/G<ZHXNAC7#&5EB*G)%
MQJ)*/-"[2T25FFI+KMO8^6J]T\D*`"@`H`]>_9\_Y+W\$/\`LKWPU_\`4ST6
MO/S?_D4YG_V"8G_TS,[<M_Y&&`_["*'_`*=B?K+^UI^S?\-?BY\6M/UWQ1^T
MCX&^%>O-X6T31+7P=K]OH%QJ]Y#%J.KO::C;QZCX\T>XDCNI[R6"-$LV!>U8
M+([$JGP'#^<XW+LOG2H9+7QU)59S=:FZBA%\L$XOEH5$G%13?O;/9=?K\XRS
M"XS&1J5<SI82I[.,53FH.32<K-7JP>K=E[O3<\O_`."@\+_#WX)_`CX,Z/I>
MJZAX2T::REMO&U]-;2QS7'@WPU+X?TW2Y?LB;1?7=CKEW>L66UC*V@%JDRI-
M]C[N$6L7F>:YE4J1AB*B:=&*:LJM15)25_LQE!15N9W?O-7CS<O$:^JX#+\#
M3A*5&FU:JVMZ4.2,=.K4G+HM/=O9\OY&5^@GQI^ZWQ&T'X#Z_P#LD?LTVOQ^
M\:^)O`_AF#P?\,9]&U'PO:7%W>76NCX9Q1I97"6WA+7V6V.GO>R[C;0C="@\
MW)V/^6X.KFM'B#.GE&&IXFNZV)4XU6DE#ZR]5>K2UYE%?$]&].J^_P`33R^I
MD^5K,:\\/2C3H.+IIMN?L%H[4ZFEKO9;;]#\UOCOX1_9(\/^%=+N_@%\4/'7
MC?Q9+X@M[?5=+\4:?>VEC:^'6T[4Y;B_@DN?AWH"F[74HM+B"B[E.RYD/DL`
M7B^TRK$<05:\XYM@:&%P\:;<)4I1<G4YHI1:6(JZ<KD_A6J6O1_+YA1R>E1@
M\NQ=6O6YTI1FFDH<LKM7HT]5)16[T;TZKY2KWCR#]9-0_P"45VA?]A6;_P!7
MKK-?`P_Y+NK_`(5_Z@P/L)?\DE3_`,3_`/4J1^3=??'QX4`?ME\+]*^%FL_\
M$Z_!NG_&7Q)K7A+X?RWNLMJVN>'X)KG5+6XB^,GB&32XX(8-`UEV2;4EMHGQ
MI\N$D8EHP-Z_F>.GCJ7&&)GEM&%?%QC#DA4:46OJ=-2NW4IK2-VO?6JZ['W6
M$AA)\-4(XZK*AAFY<TX)N2:Q,^6R4)[NR?NOY;GP]\7?!'[$>C?#_6]0^#OQ
MA^(WBOXAP/I8T+0=?TS4+;2KQ)=7L8=5-S-/\+='1##H\E_.F=1@S)`@`D)$
M4GU&7XKB>IBZ4,QR[#T,&^;GG3E%RC:$G"R6*J/6:BG[CT;VW7@XRAD5/#5)
M8+&UJV)CR\D)Q:B_>2E=NA#:-VO>6JZ[/XNKZ0\,_3?_`()E_#9=8^(7C'XI
M:A:-)8^!-"31M%DETZ293XA\3>:+FZTZ]Y`O;+0+"_MIH($>7R_$L.YD615N
M/B>-L;[+!X;`0E:6*GSS2E;]W2M92C_+*I*+3;2O3>]KKZKA;"\^)K8J2]W#
MPY8>[]N>[B^\8)II:VFMKZ_5KV7Q$_:/_9:^.GAWQYX&\:^$O%,/BKQIK7@/
M2_%6B7/AO6;_`$^TU2/Q]X(LH4UJQMX1&LLC^&Y&1I$$-J2;E7D\R+P%+!Y+
MGN55<)BJ->A[*C"O*E-5(1DX^PK-\DF]E[9;.[^%I6?K\N)S/*<?2Q&'JT*J
MJ594HU(N$FE+VU)>\DO^G3W5E\2;NOP;K]5/SX^X/V'_`-HCP9\"?%?C"P^(
M,-W#X5\>Z5IEG<ZY8VLU_+HMYHDFI/:_:K&T1KJ;3KF#5;V.1[199DECMB(6
M1G>#YCB?)\3FF'PTL&TZ^$E)JG)J*FI\J=I/W5*+A%I2LFN;5.R?O9#F5#+Z
MU:.)3C1Q$8IR2;Y'#FM=+7E:DT[7:=M+7:^P/`7[._[/^L^)4\7_`+)/[2EY
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M_P#\C?"?]Q?_`$S4/L?]HCP+^PQJOQF\<ZA\5?C-\2?#/Q`N;W3F\2:'HFEZ
MA/I>GW":'I<5I':30_"G54='TU+*5MNH7/SS.-RD;$^<R?%<4T\MPL,!EN&K
MX2,9>SG.45*2YY7NGBJ;TE=?!'1==W[>98?()XZO+%XZO1Q+<>>$8OE3Y8I6
M:P\_LV?Q/]#\O_BOIOPXTCX@>(=.^$>OZOXH^'EL^G#PYKNNPRV^JWZ2:1I\
MVI&[AFT32'0Q:Q)J$";M.MLQP(0'!$LGW&`GC)X2C/,*,*&,?-[2G!IPC:<E
M&S4ZBU@HM^^]6]ME\IBXX:GB*D,'4E5PT>7DG-6D_=3E=.,-I72]U:+KN_/*
M[#F"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"
M@`H`*`"@#X6\7?\`(U^)_P#L8=:_].5S7X9F_P#R-LS_`.PO$_\`IZ9^L9;_
M`,B_`?\`8/0_]-1/V$_;8_Y/`_:#_P"QA^'O_JB_A17Z%P1_R*<1_P!A=3_T
MS0/C>*O^1A1_[!X?^G:Q\R5]B?,A0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`'Z%_M'_'+X6^/?V6_V??ASX3\4?VKX
MS\#Z?X#@\4:-_8GB*Q_LN71?AW-H6I+_`&AJ6D6]C>^3JK+!FTN9P^=\9>/Y
MZ^0R;*\=@\]S?&8BA[/#8F5=TI\].7,IXA3C[L9N4;QU]Z*ML[/0^DS/'X3$
M93EN%HU>:O05)5(\LUR\E'DEK**B[2TT;[K34_/2OKSYL*`/T+O/CE\+9?V`
MM)^"<?BC=\3K74))Y_#/]B>(ALB;XL:EXE5O[9;2!I3?\22XAN<+?$_/Y>/.
M!C'R$<KQT>+*F9^PM@91253GI[_58TO@Y_:?&G'X//;4^DEC\)_J[#`JK_M4
M7=PY9_\`01*?Q<O)\+3^+RWT)_V$_CS\-/A#HWQDT;XF^,9/#-OXJM_"W_"-
M03:3XGUJQFO+:U\66FLSB'P]I&H"RD*7NB+)))'&TR11@&3[/A%Q3E.-S"IE
MM3`X95GAW5]HU.E"23=)P5ZDX<R]V=DF[-O:^KX?S#"X*GC:>*K^Q554^1<M
M22NE44G:$96WC=M*Z2WL?GE<1)!//#%<0W<<,TD4=U;K.L%RD;LB7$"W4$,R
MPR*`ZB:&*0*PWHC94?7Q=TG9Q;2T=KKR=FU=;.S:[-GS;5FTFFD]&KV]5=)V
M]4GY(_0[]@GXX?"3X.VOQCL_BGXL?PM'XPM_!-MH[1Z)XCUE[Q-,C\:Q:J4.
M@:+J`M7@76+#!N5C#F?Y`_EOL^0XKRO,,PEELL!A_;O#.LY^_3AR\WL7#^).
M%[\DOAO:VMKH^DX>Q^#P2QL<76]BJRI*/NSE?E]JI?!&5K<RWMOI>S)_^%:_
M\$U?^C@_B]_X)=5_^<A2^N\:?]"C"?\`@<?_`)M']5X7_P"ACB/_``&7_P`R
MGP1XQMO#5EXN\4V?@O4+S5O!UIXCURV\)ZKJ"/%?ZGX:M]3NHM"U"^CDL;)H
M[RXTM+6:56L[0AY&!@B(\M/J\-*M+#T)8F"I8F5.#JPC\,*CBG.,6I2TC*Z7
MO2T7Q/<^>K*E&M5C0DY4(SDJ<GHW!2:@VK1LW&S?NK7HMCZL_8R_:,\*_`3Q
M-XJLO'>D7FH>#_'MGHMAJ=[I]M#?76C7.DW&H):7LMA+)&;O3/LVM:C]I6!G
MN`J(889G_=MX/$F35\UH8>6%J*&(PCG*,9-Q4U-1O%22=I7A'EO:.]W%:GKY
M'F='+JM6.(@Y4:ZBI.*NXN+=G9VO&TI<UM>R>Q]/>!/$/_!.?X1>-U^*G@[Q
MOXUU#7M+\ZX\/>&9=+\=7&GZ)/<6%QI\ZZ6+_P`*63W,DEM=3J?[7UB^16DW
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M>+X-?76AXN_X1.+2/'R:$_BA=5.N?VGY/_"(M/'<G4B'^RIK2:>`HC$`CX/S
M"I\9+!?V;]5I.CR>R]JYT.?V7+R<M_:VMRZ<SI.IUYKGO<_#'UKZ[[>I&HI>
MT]GRU>3VG-S\UO9W3YNG.H=+6/BO]K3XY:?\?_BY<>,-$T^YT_P]I.B6/A3P
M^M]A;Z\TS3+S4[\ZC=PJS+:R7%]JUZZP!F*1&(.?,WU]+P_E<\HR^.&JS4JT
MYRJU.7X8RDHQY4^O+&$4WU=[:6/#SC'QS#&.M3BXTX15.%]W&+D[M=+N3TZ*
MW4^9J]L\H*`"@`H`]&^#NO:3X5^+GPL\3Z]=_8-"\-_$?P/KVLWWD7-U]CTG
M1_$VEZAJ-W]FLH9KBX\FSMYI/*@BEE?9MC1F(4\>8TJE?+\?0I1YJM;#UJ<(
MW2O.=.48J[:2NVE=M)=6D=6"J0HXS"5:CY:=*M2G)V;M&,XN3LDV[)-V2;[(
M]^_;@^*G@+XO_&6R\5_#K7?^$AT"'P1HFCR7_P#9>LZ3MU&SU+7;BXM_LNNZ
M=97)V17ELWF"$QGS,*Q*L%\GA?`8O+LMEA\92]A5=:<U'FA/W7&"3O"4H[Q>
ME[Z;'H9]B\/C<;&KA:GM*:I1C?EE'5.3:M-1>EUTL>J?M(_'7X8_$[]EWX'>
M"M"\<C5_B%X)L_`K^+-'U#1_%\6H/?:?X&ET'6V36;_01IVH7$6K3%Y)?[0(
MF4-)&\K$!N#)<JQV!SS-,35POLL'B77]E.,Z7+RNNIP]R,^>*<%9+DTV:1V9
MGC\)BLIP%"GB.;$X=4O:1<:B=U2Y)>\X<K:EN^;7=7/SGK[$^9/U]U;XJ?L:
M_%O]G_X*?"_XI?%WQ-X=O?`/A3P*;^W\+^&O%:7EMXBT3P5!X>U"PN+VY^'F
MKV=W;0RS7B[[7*NT2/',T?W_`,\IX#B/+\VS/'8'+Z=:.+JU^5U:E*SISK.I
M&2BL13DFTEI+9-II/;[.>+R3&9=@<)B\9.D\-3I75.%2ZG"DH--NC.+2UV^3
ML?*WQ;\#_L0:/\/O$&H_!_XQ?$?Q5\1;?^RO^$=T'7M+U"VTF_\`-UO38-6^
MUS3_``LT=$\C0I=3N(\ZC;YEMXP/,)$4OO9?BN)ZF+HPS#+L/0P;YO:5*<HN
M<;0DX62Q51ZS44_<>C>VZ\C&4,AIX:I+!8VM6Q,>7DA.+47[T5*[="&T.9KW
MEJEOL_BNOI3PS]:/@O\`&G]E*_\`V3/!_P`#/C9XXN].GMY];N-?T.QT'QXU
MQ#)_PL/7O$VC[=7T'PW=0,K03Z?<$6]P_#^7)M8.@^`S++,^IY_B,SRS"J2:
M@J<Y3H6_W>G2G[E2I%Z-26L5W71GV&!QV42R>A@,=7<7%R<X*%6_\:<X^]"#
M6S3T?D^IXK\;=)_8)M?AAXFF^"OB?7-0^)D?]B_\(U9WEO\`$A+:;=X@TE-9
M\QM>\/6U@-F@-JKCSYT^9%$>Z78K>GEE3BMXZ@LRH0A@O?\`:-/#W7[N?)_#
MJ2G_`!.5:)^>ESAQT.'HX2K]1JSEBER\B:K6^./-\<%'2'-NUY:V/@&OK#YT
M_5GX5?%W]EK7OV/_``I\`OC%\3-:\*7L=QJ]SKEKX?\`#OBBXU2R=/B/K?BK
M21!JD/@G6=-D2:VEL)'"+.0D[1DQRJ=GP>/R_/:/$5?-<NP,*\;05-U*E)1?
M^SPI2O%UJ<U9J26VJOJM_KL)C,IJ9+1R[&XJ5&2<G)0A4<E:M*I&TE2G'5-7
MWWMHSQWQC\/O^"?=EX1\4WG@OXY?%/5O&%IX<URY\)Z3J&D:E%8:GXEM],NI
M="T^^DD^#UDL=G<:HEK#*S7EH`DC$SQ`>8GHX;%\72Q%".)RO"TL-*I!591G
M'FA3<DIRBEBY:QC=KW9:KX7L<5;#<.1HU70Q]>5:,).G%QDDYJ+Y(O\`V:-D
MY63]Y:=5N?!%?5GSQ^G_`,+_`-I/X7?`']DB_P##?PV\:QW'QXUV>37;NS'A
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M6VQ\#?&4>`O^%I>.)?A?J,>J>`+O7KG4?#%S#IM[I$$6GZFL>H'3K?3=0L+*
MXM+;3[FYGL(TDMHODLD9=R,KM]9EOUOZAA5CH>SQ<::C43DIOFA[O,Y1E)-S
M24W:3UET>A\[COJZQ=?ZI+FPSFY4WRN*2>O*HM1:46W%:+1'T'^QE^T9X5^`
MGB;Q59>.](O-0\'^/;/1;#4[W3[:&^NM&N=)N-02TO9;"62,W>F?9M:U'[2L
M#/<!40PPS/\`NV\CB3)J^:T,/+"U%#$81SE&,FXJ:FHWBI).TKPCRWM'>[BM
M3TLCS.CEU6K'$0<J-=14G%7<7%NSL[7C:4N:VO9/8^GO`GB'_@G/\(O&Z_%3
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MOL=G^R5X\\)_#']H/X?^./'&J_V'X7T/_A*O[4U3[#J6I?9?[2\$^)-(LO\`
M0M(L[J[F\S4;^TB_=02;?-WOM169>?B#"8C&Y1B\+A:?M*]3V7+'FC&_+6IS
ME[TW&*M&+>K6UEK9&^3XBCA,QPU>O/V=&G[3FE:3M>E.*TBFWJTM%^!]F?%&
M/_@GC\6O'OB+XB>(_CS\2;'6O$UQ:7-_:Z)X>\06VEPO9Z=9Z9$+2"_^#UY/
M&A@LHF827,IWLY!"D*OS>`?%^7X2C@Z.58:5*@FHN=2FY:R<G=QQ<5O)[16A
M[>+7#>,Q%3$U<PKQG5:;483459**LGAI-:+JV?"'QVT/X'^'_%VG6?P"\8^(
M_&_@Z3PY9W.I:KXGM;BTO[?Q*^IZQ%>:?#'<^%=`8V<>EPZ-,K"SD&^[E'GL
M08X?JLJJYI5P\Y9MAJ>%Q*J-1A2:<?9\L'&3:JU=>9S7Q+1+W5N_G\PIX"E6
MC'+JTZ]#D3E*:::GS23C9TZ>BBHOX7JWKT7BM>D<(4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`?"WB[_`)&OQ/\`
M]C#K7_IRN:_#,W_Y&V9_]A>)_P#3TS]8RW_D7X#_`+!Z'_IJ)^PG[;'_`">!
M^T'_`-C#\/?_`%1?PHK]"X(_Y%.(_P"PNI_Z9H'QO%7_`",*/_8/#_T[6/F2
MOL3YD*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
M`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"
M@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`
M*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`/A;Q=_P`C
M7XG_`.QAUK_TY7-?AF;_`/(VS/\`["\3_P"GIGZQEO\`R+\!_P!@]#_TU$_M
M\\5?L^?`/QUKM[XH\;?!#X0>,?$VI"V&H^(O%7PU\&>(==OQ96D%A9B]U?5]
M%N+JZ$%C:VUM$)96\N*WBC3"1JH\X[3GO^&3OV6/^C:?@!_X9OX=?_,Y0`?\
M,G?LL?\`1M/P`_\`#-_#K_YG*`#_`(9._98_Z-I^`'_AF_AU_P#,Y0`?\,G?
MLL?]&T_`#_PS?PZ_^9R@`_X9._98_P"C:?@!_P"&;^'7_P`SE`!_PR=^RQ_T
M;3\`/_#-_#K_`.9R@`_X9._98_Z-I^`'_AF_AU_\SE`!_P`,G?LL?]&T_`#_
M`,,W\.O_`)G*`#_AD[]EC_HVGX`?^&;^'7_S.4`'_#)W[+'_`$;3\`/_``S?
MPZ_^9R@`_P"&3OV6/^C:?@!_X9OX=?\`S.4`'_#)W[+'_1M/P`_\,W\.O_F<
MH`/^&3OV6/\`HVGX`?\`AF_AU_\`,Y0`?\,G?LL?]&T_`#_PS?PZ_P#F<H`/
M^&3OV6/^C:?@!_X9OX=?_,Y0`?\`#)W[+'_1M/P`_P##-_#K_P"9R@`_X9._
M98_Z-I^`'_AF_AU_\SE`!_PR=^RQ_P!&T_`#_P`,W\.O_F<H`/\`AD[]EC_H
MVGX`?^&;^'7_`,SE`!_PR=^RQ_T;3\`/_#-_#K_YG*`#_AD[]EC_`*-I^`'_
M`(9OX=?_`#.4`'_#)W[+'_1M/P`_\,W\.O\`YG*`#_AD[]EC_HVGX`?^&;^'
M7_S.4`'_``R=^RQ_T;3\`/\`PS?PZ_\`F<H`/^&3OV6/^C:?@!_X9OX=?_,Y
M0`?\,G?LL?\`1M/P`_\`#-_#K_YG*`#_`(9._98_Z-I^`'_AF_AU_P#,Y0`?
M\,G?LL?]&T_`#_PS?PZ_^9R@`_X9._98_P"C:?@!_P"&;^'7_P`SE`!_PR=^
MRQ_T;3\`/_#-_#K_`.9R@`_X9._98_Z-I^`'_AF_AU_\SE`!_P`,G?LL?]&T
M_`#_`,,W\.O_`)G*`#_AD[]EC_HVGX`?^&;^'7_S.4`'_#)W[+'_`$;3\`/_
M``S?PZ_^9R@`_P"&3OV6/^C:?@!_X9OX=?\`S.4`'_#)W[+'_1M/P`_\,W\.
MO_F<H`/^&3OV6/\`HVGX`?\`AF_AU_\`,Y0`?\,G?LL?]&T_`#_PS?PZ_P#F
M<H`/^&3OV6/^C:?@!_X9OX=?_,Y0`?\`#)W[+'_1M/P`_P##-_#K_P"9R@`_
MX9._98_Z-I^`'_AF_AU_\SE`!_PR=^RQ_P!&T_`#_P`,W\.O_F<H`/\`AD[]
MEC_HVGX`?^&;^'7_`,SE`!_PR=^RQ_T;3\`/_#-_#K_YG*`#_AD[]EC_`*-I
M^`'_`(9OX=?_`#.4`'_#)W[+'_1M/P`_\,W\.O\`YG*`#_AD[]EC_HVGX`?^
M&;^'7_S.4`'_``R=^RQ_T;3\`/\`PS?PZ_\`F<H`/^&3OV6/^C:?@!_X9OX=
M?_,Y0`?\,G?LL?\`1M/P`_\`#-_#K_YG*`#_`(9._98_Z-I^`'_AF_AU_P#,
MY0`?\,G?LL?]&T_`#_PS?PZ_^9R@`_X9._98_P"C:?@!_P"&;^'7_P`SE`!_
MPR=^RQ_T;3\`/_#-_#K_`.9R@`_X9._98_Z-I^`'_AF_AU_\SE`!_P`,G?LL
M?]&T_`#_`,,W\.O_`)G*`#_AD[]EC_HVGX`?^&;^'7_S.4`'_#)W[+'_`$;3
M\`/_``S?PZ_^9R@`_P"&3OV6/^C:?@!_X9OX=?\`S.4`'_#)W[+'_1M/P`_\
M,W\.O_F<H`/^&3OV6/\`HVGX`?\`AF_AU_\`,Y0`?\,G?LL?]&T_`#_PS?PZ
M_P#F<H`/^&3OV6/^C:?@!_X9OX=?_,Y0`?\`#)W[+'_1M/P`_P##-_#K_P"9
MR@`_X9._98_Z-I^`'_AF_AU_\SE`!_PR=^RQ_P!&T_`#_P`,W\.O_F<H`/\`
MAD[]EC_HVGX`?^&;^'7_`,SE`!_PR=^RQ_T;3\`/_#-_#K_YG*`#_AD[]EC_
M`*-I^`'_`(9OX=?_`#.4`'_#)W[+'_1M/P`_\,W\.O\`YG*`#_AD[]EC_HVG
MX`?^&;^'7_S.4`'_``R=^RQ_T;3\`/\`PS?PZ_\`F<H`/^&3OV6/^C:?@!_X
M9OX=?_,Y0`?\,G?LL?\`1M/P`_\`#-_#K_YG*`#_`(9._98_Z-I^`'_AF_AU
M_P#,Y0`?\,G?LL?]&T_`#_PS?PZ_^9R@`_X9._98_P"C:?@!_P"&;^'7_P`S
ME`!_PR=^RQ_T;3\`/_#-_#K_`.9R@`_X9._98_Z-I^`'_AF_AU_\SE`!_P`,
MG?LL?]&T_`#_`,,W\.O_`)G*`#_AD[]EC_HVGX`?^&;^'7_S.4`'_#)W[+'_
M`$;3\`/_``S?PZ_^9R@`_P"&3OV6/^C:?@!_X9OX=?\`S.4`'_#)W[+'_1M/
MP`_\,W\.O_F<H`/^&3OV6/\`HVGX`?\`AF_AU_\`,Y0`?\,G?LL?]&T_`#_P
MS?PZ_P#F<H`/^&3OV6/^C:?@!_X9OX=?_,Y0`?\`#)W[+'_1M/P`_P##-_#K
M_P"9R@`_X9._98_Z-I^`'_AF_AU_\SE`!_PR=^RQ_P!&T_`#_P`,W\.O_F<H
M`/\`AD[]EC_HVGX`?^&;^'7_`,SE`!_PR=^RQ_T;3\`/_#-_#K_YG*`#_AD[
M]EC_`*-I^`'_`(9OX=?_`#.4`'_#)W[+'_1M/P`_\,W\.O\`YG*`#_AD[]EC
M_HVGX`?^&;^'7_S.4`'_``R=^RQ_T;3\`/\`PS?PZ_\`F<H`/^&3OV6/^C:?
M@!_X9OX=?_,Y0`?\,G?LL?\`1M/P`_\`#-_#K_YG*`)Q^RQ^S$H"K^SC\!U5
M0`JCX0?#X``#```\/<`#M0![S0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`
M!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4
M`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`
M4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`
M!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4
M`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!S/C3Q/
M8^"?"7B3Q;J3HECX;T74=7N"Y(4K8VTDZQ9'.9)%2,8[N*Z\!@ZF/QN$P-)-
MU,55A2BEO[\DK_):_(X\PQE++L#B\=6:C2PE*I5E?:T(MV^;5OF?/O[)W[0=
M]^T#X)UO5]=LM'TOQ-X>U^73=1L-$CO(;'^S[F%+K1[R.*_OKN93)&+J%V,Q
M#26,K*J*0H^GXTX9I<,YA0H86I5K8/$T5.G.JXN7/!\M6-X0A&R=I17+=1G%
M-MZGRW`W%-7BC+<1B,52I4,9A*[IU*=%24/9R7-1E:<ZDKN-XR?-9RA)I):+
MZHKXT^U"@`H`*`"@`H`*`"@#R7XI7/QLMH]'_P"%.:?\/;^5I+H:X/'CZTD<
M406+[&=._L>_MCO+F;S/,W\!-H'->UD\,@DZ_P#;E7&TDE'V/U-4KWUYN?VL
M)Z6MRVMUN>'G,^(J:P_]@4L#4;<O;?7'522LN3V?LIPUO?FO?I8_-30/^"A'
MQEOO'.B^$=1\(_#.%+OQ5IWAZ_FM+#Q09(TGU:'3KN2U>7Q2R^8%:0QLZ,H.
MTLK#*G]8K^&.14\OKXRECL<W3PU2O!2GA[>[1=6*DEAT[:)22:>]FC\AP_BG
MG]3,</@:N`R^*GBJ>'FXPQ%US5HTI.+>(:NKMQNFMKIG["U^&G[T%`!0`4`%
M`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!'++'!%)-*ZQ10Q
MO++(Y"I''&I9W8GHJJ"2?04FU"+DWRQBFVWLDM6_DA2DH1<I/EC%-MO9):MO
MT1\[_&7XLW&C_#:V\8_#/6M)U11XCTJSN=1MC;ZI:06KF=Y;>ZC!/D^=+%!`
MV[RW47`*E2RFODN(<]GALGAF&38BE72Q%*$JD>6I",7=N,E]GF:C%WLTI:6;
M3/C.)N(9X7)(9GD6)HUTL32A*I'EJPC!\S<9)7Y>9J,'>TDI:6;3/"_CM\9?
M$.J>&?A9<>'KJ]\.#Q!I7_"87K6,\D$PO[&YBMK:T$RD-+9P7L=S+M)*R#R2
MX(`%?,<4<18NM@LCGA)SP?UNE];GR2:?/"2C&%UJX1FI.VTERW3/D^+>)L97
MP&03P52>!^N4OKDW"3B^>G)1C#F5FX1FI2L])>[S)H[7QO\`'SQ;96GP<L?#
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M5::F[74=84`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`%`!0`4`%`!0`4`%`!0`4`?`?_``4,^(;>&/A!8^#+&8KJ?C_5UMY8XF*R
MC0-"$>HZI+M7K$UTVF0/G@K<MZ5^E>&&6?6\\J8^I']UE=+FBWM[:K>%)>J7
M/)><4?F'BIFOU+(*>7TY<M7-*JC)+?V%&U2J_1OV<'Y29\0_\$_/B-_PAWQJ
M'A>[G$6E_$+2Y=$*.S",:S8[M0T60*./-9DO+52?^@A^7Z!XE95]=X?^N4XW
MK974573?V4_<JKR2O&;_`,)^=>%V;?V?Q%]2G+EH9K2=*S>GMJ?OTG;N[2@O
M\3/W:K^=3^E`H`*`"@`H`*`.)\:_$CP)\.+:SO/'7BK1_"UK?RRPV,VKW2VR
M74L""26.'()=E1E)`'0BO0P&59CF<YT\NP=7%SHI.:I1YN5-V3?9-Z'G9AFV
M693"G/,L;2P4*K<8.K+E4FE=I=VEJ1^!?B9X#^)=KJ%[X#\3Z;XFM-*N8[._
MN--:9HK6YEB\Z*)VEB3):+Y@5W#'>GF.49EE$Z5/,L'4P4ZT7.$:B2<HIV;2
M3>B>FMB<LSG*\XIU:N5XVGC*="2A.5-MJ,K746VEK;70[JO./3/YC_#W_);]
M$_[*?I__`*E,5?UO7_Y$-?\`[%M3_P!1)'\=8;_DH</_`-C.G_ZEQ/Z<*_D@
M_L4*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#YA^
M)/QQN?`?CQO!?BSPQ_Q1>NV%M%:^(;.YE6]-MJ,7V2_G\B6,PW`M;EY4>*-U
MD5-CC<6"M\7G'$L\KS3^S<=@O^$[$PBHUX2?/RS7)-\K7++DDVI134DK/6Z3
M^$SOBJ>49O\`V7F.`_X2\73BH8B$FI\M1<E1\K7++V<FU*,6I*-I:W2?DWPF
M^$?CKP/\3=3T#6M$.H?#O5--U6UUF]FCAN_#>MZ7%$T^CS2PNS!=06<08C>-
M9(]TP!V\GP<AR#,\LSJMA<3AO;916IU8U9R2GAZU-+FI-Q=U[1/ET:YH^]TU
M/G>'>',VRG/:^#Q6%]MDM>G5A6G)1GAJ])+FHMQ=_P!XI<MDX\T?>6VIVVCS
M_"+]HZU'A^ZTF\\,77P_FD.F6ME=6]H9?"Z3K;9MIHX-@TV:*"`30&-7MW:-
MD?YM[>GAY9!Q?#ZI.A/!3RF3]G&$HPOADU'W6E;V<E&*G&R=-V:>MWZN&GPY
MQM3^I3PT\#4R>3]E"$HPOA5)0]V25O9248J<+*5-\KC+6[U-(^('A+Q_+XMT
M/X>>$[9O$'PV\(WL?P\URXMK661PD+Z:IT598S)9(EQ%9BW9Y"TN\.0@)#;8
M?-<!FDL?A<HP,7B\GPLU@*THQ;T3I_N4U>"4E#D;=Y73=NO1ALXR[-Y9CA<F
MR^+QF1X2:RZO*,&W:+I+V":YH*,E!0;=Y73]W6_A_P`/K76O@-9:S\5_B#HV
MH)J^KJ?#GAS0KVX2+4]3U#4)1J.I:GJL[-*;.W5+%<M('E<ER$Y4GYG*:>)X
M7IXC/<VPU18BNOJ^'HSDE4J5)OVE2I5E[W)%*&[O)ZZ;'RF34\5PC2Q7$.<X
M:I'$XC_9L-0G)*K5J5'[2I5JRO+DBE#=WD]=-C[6^%'BW7_'/@RP\3^(=$@T
M"YU.>ZDLK*WDG=7TM)-EE>-]I59%,ZJ[C(`*;'7AQ7Z1D6/Q699=2QN*PRPD
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MTZD92I/EFHR3<'VDD[Q?D[,LU!84`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`'P+/X=LOVAOVF/BO;:HBW?@SX5_#FX
M^&=D)8@]L/%?C""Z75KM`V0;FU4ZA$67E6L;8\<5^DQQ53A?A+)946Z>.SC'
M1Q\K.TOJV%:5*-UM&;Y79Z-2F?F$L)3XIXPSN-9*>7Y'@)9="ZO'ZSBXOVLK
M;<T%S*ZU7+`_&YUU[X4?$=D(DL_$'@/Q7@@[X&2_T#4^X!W+&TMMTR<JW?-?
MNJ>&SC+%M+"9GAO5<E:G^/*WIYH_`6L5D>:-:PQ>4XKT?/0J?AS*/W2/Z9/!
M7BBP\;>$?#7B[3'5[#Q'HFG:Q;,F=H2^M8YS'SSF-V9"#R"AK^3,?@ZF7XW%
MX&JG&IA*LZ4D^\).-_FE<_L'+L92S#`8/'47>EBZ-.K&W:<4[?)NWR+VO^(M
M!\*Z9+K/B36--T+2;=X8I]2U6[@L;*&2XD6&!)+BX=41I)65%!/+,`.36>&P
MN(QE6-#"4)XBM)-JG3BYS:BKNT8IMV2N^R-,3BL-@J,L1BZ]/#4(M)U*DE""
M;=HIRDTE=NR\S@A\=?@QCCXI^`\>WBC2.W_;U7I?ZO9ZO^9/C%_W+U?_`)$\
MS_67A_\`Z'6"_P#"BE_\D;OB+XF_#[PEH%GXG\1^,?#^CZ!J$,<^FZG=ZE;K
M;ZE#*B21OIH1V?4`T<B,/LZR':P/0USX7*,SQN)G@\)@*U?$TFXSIPIR<J;3
M::GI:%FFO>:U5CIQ><95@,+#&XO,*&'PM1*4*DZD5&::33AK>>C3]U/34X;P
MU^TM\"/%NJ0Z+H/Q-\-W6IW#^7;6EQ+<Z6UQ(2%6.W?5;:VCFE9B`J(Y9B0`
M"2!7HXSA+B3`477Q63XBE1@KRDHJ:BN[5-R:2ZMJRZGF8+C'AC'UHX?"9UAJ
MM:3M&#DX.3Z*+J**;?1)W?1'M\LL<$4DTKK%#"CRRR.P5(XXU+.[L>%55!))
MZ`5\]%-M1BKMM));WV22/I&U!.3:C&*;;>R2U;?DC\D?^"B/C_P/XQ\-_#FW
M\)^+O#WB.XL-;UM[V#1=6L]1EM(Y+*U1'N$M97,*,Z,H+8R5/I7[7X7Y;F&`
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MV=I1;6C5GV9_-1X>_P"2WZ)_V4_3_P#U*8J_K"O_`,B&O_V+:G_J)(_D+#?\
ME#A_^QG3_P#4N)_11XX^,'PP^&S11>./''A_PY<3`-%97MZKZBZ$;ED73;42
MW1C*@D/Y.TX.#P:_E[+LBSC-K_V;EU?%J.CE"#Y+]N=VA==N:Z/ZNS+/\ER>
MW]IYE0P;>T9S7/;H^2-YV[/EL<[X2_:+^"/CG4X=%\,?$CPY?ZM.=MMITL\^
MFW5RY8*L=K'JD%M]IE+$`1Q;V.1@5U8[A7B'+:+KXW*<10HQWGRJ<8KO)TW+
ME2ZMV2.3+^+>&\SK1P^!SC#UJ\M(PYG"3?11511YF^B5V^Q[57SY]$,=TB1Y
M)'6..-6=W=@B(B`LSNS$!550222``*:3;22NWHDM[]$D)M13;:BHJ[;T22W;
M?1(\$UK]J3]G[P_J,NE:E\4O#:WMO*89TLGO-5BAD7JKW6EVEQ!D<9`D.*^E
MPW!O%&+HQK4,EQ$J<E>+E&,&UY1G*,OP/E\3QMPI@JSP]?/,-&K!V:C*51+U
ME3C*/XGI'@OXD>`OB':/>>!_%NA>)H(1F==*OX9[BV!;:#=6987%J"W`,L29
M(('(KR<?E6995-4LPP-;!R>WM(.*?^&7PRMY-V/8R_-\LS6FZF6XZCC(1W]E
M-2<?\4?BCY72)O$WQ!\#>"IK2W\7>+O#WAF>^CDFLHM;U:STV2ZBA94ED@6Z
ME0RHCLH)7."14X3+,QQT9RP.!KXJ-)I2=*G.:BVFTFXIV;2=K]BL9FF6Y?*G
M#'8ZAA)5$W"-:K"FY*+2;BI-72;2=MKF'8_&;X2ZE>6FG:=\2/!5]?WUQ#:6
M5G:^(]+GN;JYG=8H(((8[DM+*\C*JJH))(`Y-=%3(LZHTYU:N58JG3I1<I2E
M0J*,8Q5VVW&R26K;V.:EQ!D=:I"E2S;"5*M22C"$:]-RE)NT8Q2E=MO1)%?Q
MM\</A)\.+I;#QIX^\/:%J!&[^S9KLW.I(N`P:73[!)[B%2K`@R1J"#D5>7<.
MYYFL>?+LLKXFFOMQA:'RG+EB[=;-V(S+B3(<GDJ>99KA\)4_DE.\_*\(<TEY
M72&^!OCC\)/B1>/IW@CQ[H&NZE&GF'38;B2UU%HU!9GBL+^*">=%56+-%&X4
M`DD"GF/#N=Y1!5,QRROA:3T4Y1O#RO.#E%7Z7:N++.),ASB;I99FE#%58Z^S
MC+EG9;VA-1D[=;)V-OQM\3OA]\-[:*Z\<^+]#\,QS\VT>IWL<=W<@$J6M;&/
M?<W*!AM+11,`>"<FN;+\HS/-9NGEN!K8N4=_9P;C'RE+2,7Y-HZ<RSG*LGIJ
MIF>/HX*,OA52:4G_`(8*\I)=6HM(XOPM^TC\#/&6J0:)X=^)?AR\U6Y;9:V,
M\UQIDUS)D*L5M_:MM;+/*Q("QQLS,6``).*]#&\)\1Y=1=?%Y/B*-&.LIJ*F
MHKO+V;DXI=6[)=SSL#Q?PSF-:.&P6<X>K6EI&#DZ;D^BC[104F^B3;?1'M]?
M/'T@4`%`!0`4`%`!0`4`%`!0`4`1RJ[Q2)%)Y$C1NL<H17\EV4A)/+;Y7VL0
M=IX.,&E)/E:B^5V:3M>SZ.ST=NPI)\K47RNS2=KV?1V>CMO8^"Y-3_:!T+Q[
M8:+XT\-O\1]#.N0A/M/A73M3TBXLWN%0ZIH^H0V`71[J&V<3;9'3RRFV5"`#
M7Y<ZW%>%S2EALQP;SC"^V5N;#4ZE)P<K>TI5%"U&48OFLVN5JTE;4_)'7XQP
MF;T<+FF!>=X3V\;<V$IU*+@Y6]K1J1IVHSC%\UI-<K5I)K4Z7XB>.OC+\,/B
MA+/Y=_XF\`:U>VTFG:<-+%W:?89A%%=Z7;W5G;&:PU*WD,I02.PD5HV975CM
M[,WS/B+),[<K3QF58F<73I^RYH\CLI4HRA'FA4@[VNVI*S::;MVYUFW$V0Y\
MY\M3'Y/BIQ=.FJ7/#D=E.E&<(\U.K!WY>9M233::;MT_@G]G!_"GC3Q3KD7B
M`?\`"/:SH&N:3H]E%#+%JM@OB+`E2])_=.+*,8B9&R[;2RH5.>W+>#_J&8X[
M$QQ7^R8BA6I4H)-5(*ONI_9?LUI%K5NUTK'?E7!+R[-,PQ<<9_L6*H5Z5&"B
MU5IK$;J;^%^R6D&M6[-I6U\T/@WQ/^S+X2U/7]+>+Q)XS\57UKX;LKK3],O+
MO3?#^D0K<WK7<MN4+W5[/+!$`LB+$KB-?G`(D\;^SL;P7@*V*H-8S,<=..'A
M*%.<J="DN:?,XVO*<G%:-**E9>];7P_[,Q_`F75\9AVL=F>/J1PT)TZ4YTL/
M17-/G<;7E.3BM&E!2Y5[UG?JQ??%ZR^"EUX@\4>'Y/''BW5]?@NM'TK6O#UG
MJLOAC2)(?+CU6;1H[0$3JT<DB0F/,7VR(OA0Z5W^UX@I<-SQ6-PCS/'UZ\94
M:56A"J\-2:LJKHJ*U5FU&UX\\;Z71Z"J\24>%JF,Q^#>:YCB,1&5&C6P\*KP
MM)JRJRH*"]Y6;4;7CSQYM+Q.T^`1^-6H2:IK?Q*OKRWT.:V2#1]$U/3;'3[^
M2Z,B.U\EM!:Q2Z?8Q0*8DB<+YAFW!`L8+>CPK_K'5=;$YQ5G'#2BHTJ-2G"G
M/FNGS\L8QE"$8KE47:][VLDWZ?"'^M%9U\5GE6<,+**C1H5:5.G4<KINIRQA
M&5.$8KEC%VYKW2M%-[W[17QDC^"OP]N-?M88+OQ'JERNC>&+*XR;=M2FBDED
MOKM%8,]E96T4D[JI!=A%%E?-W#]<X/X<?$F;PPDY.E@Z$?;8F<?B5.+24(/5
M*=234(M[*\K/EL=/&_%$>%<EGC*<8U,=7FJ&%IR^'VLDVYS5T^2E%.<DMVHQ
MNN:Z^+OAO^S1X_\`V@M-@^)GQE^(?B*UL]?4W>BZ;"RSZE<:>[$P7@@NLV.A
M:=(OS6UM!:.QBVN0@==WZ/G'&F4\)5I9+PWE&'E4P;Y*U22M3C42]Z'-&U6O
M4CM4G*HDI72O9GY7D7`><\9T(9]Q1G>)IT\8N>A2BU*K*FW[L^6=Z.'IRWIT
MX4VW"TGRW5_K7X*?LUZ3\#]>U[5-#\7^(=9L-=T>'3&TO6$M1]CE@NQ<K>P3
MV8BC,A7='@VP89SO/2O@>)>,L1Q-A<+0Q67X?#5<)5E456CS>^G'EY)1GS.R
MWOSV_N]3](X4X$PW">+QF(PF9XG%4<71C2=*LH^XXSYE.,H<JO;2W)=?S=#R
M;]E;P)X#\,?$CXHZAX4^+R_$#49UFMK_`$:'3M1L)M/B;6YI6OM=GO?W>I:L
MEW%);++#@8\UNDN%][CG-,UQN39%1QW#_P#9%&%I4ZSJ4YJHU1BE"A&&M.DX
M-3<9=>5?9U^=\/,GRC+\]X@K9=Q+_;%>5XU*"I5:<J477E+VF(E/2I64TZ:E
M'2W,_M:?5WCSXJ?#WX96T%SXY\5:7X?^U*S6=K<R/+J%XJ9#-:Z=:1RW,T88
M;3(L113PS"OA,JR+-\ZG*GE>`JXOV=N:44E"';FJ2<81?5)RNULF?HF<<0Y+
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M/MN?V:GRU%0Y[VY?;N"I;Z<W/R?WCZ"5E90RD,K`,K*05*D9!!'!!'.17R;5
MM+6:Z'VB:LK;=#P'Q7^U#\"_!NI3:1J_CW3I=1M96@NK;2+>_P!:^RS(<-%/
M/IEK-`DJME63S2RE2&`(KZO`<$<49C1CB,-E-2-&:O"564*/,NCC&I*,FNSY
M;-;-GQN8^('".55Y87%9S2E7IOEG"C&I7Y&MU*5*,H)K9KFNFK-([GX>_%KX
M>_%2"_G\!^([;71I1M5U.**WO;6XL&O!,UJ+B"]MH67S!;S;2H8?NSSQ7F9M
MD&;9%.E#-,'+".OS>R;E"49J%E+EE"4E[O-&^SU1ZV2\29+Q#"M/)\='%K#<
MBJI1G"5-SYN3FC4C%KFY96M=:,]&KQSW`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@#D?'WBRR\!^"?%/C&_95M/#6A:CJSA@2'>TMGD@AVKR
M3+<"*,`<DR`#FN[+,%4S',,%@*2;GBZU.DDO[TDF_DKOY'!FF.IY9EV-S"JU
M&G@Z-2J[_P!R+:7S=E\SY]_8U\*7FB?!VW\5:RI/B/XH:YJWQ!UJ9BS22_VS
M.5TW+2#>%_LZ&WE"'[K7+XZ\_3\>XRG7SZ>"P[_V3)J5/`T4MOW,;5&DM-:C
MEMV1\KX>X*IAN'X8[$IK&9U6JX^LWO\`OI?NT[Z^[34?2[/S:_X*#_#@>#_C
M/'XKLX!%I?Q$TF+5RR(5C&N:9Y>G:S'GO(Z+I]VQ[M?MZ<?J?AGFOUW('@IR
MO6RNHZ:OO[&I>=)^D7SP7E$_)O%'*?J'$*QU./+0S6DJFBT]M3M"JO5KDF_.
M9]I_\$[OB,?$_P`(M1\$WD^_4OA]K+06ZN^Z0Z!KIFO]/89.=L5\FJP`#A4B
MB'<5\%XGY7]3SNEF%./+2S.DI2=M/;4;0G\W'V<O-N1^@^%.;?7,AJY;4E>M
ME-5QBF]?85;SI_*,O:1\DHH^YO$7AGP[XMTJ;0_%.AZ3XBT:X>&6?2M:L+;4
M]/FDMI5FMY);2[CDB=XID1T)4E64$8(K\\PN+Q6!K1Q&#Q%3"5X)J-2E.5.:
M35FE*+32:=GKJC](Q6#PF.H2PV-PU+%X>33=.K"-2#<7>+<9)IN+2:TT:/Y_
M_P!L_P`.Z!X1_:$\8:%X5T72_#FBVEGX6>UTG1+&VTS3K=[CPMH]S<-#9V<<
M<4327$LLCE5&YI&8\DU_2W`6+Q6,X7P&(Q>)J8FO*>)4JE6<IS:CB*D8IRDV
MWRI)+71*Q_+WB#@L)@N*\PPV#PM+"8>%/#.-.E"-.$7+#PE)J,4DKMMNRU>I
M]Y?LC_`73_B)X+\/?%GXTVZ^-KDZ9;^'_AYX;UV);CP_X:\(Z!C3K.:/1W'V
M>XN+F:UDD0RHZA`DV&FF9U_..->)*N58[%9)D$O[.A&HZV-KT7RUJ^)J_O)I
MU5[ZC!-)I-:WCI&-G^F<"\,4LUR_"9[Q#!9C/V<:.`H5ES4,/A:'[N#5)^XY
M3<6TVFN6TM92NO'O^"A/P<\"^`X_`GC;P5H&F^%;G6+W4=%U>QT2UBT[3[R2
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MV]XQ5[NY\Q_\%#?AQ\/_``-X;^'=SX,\$^%O"MS?ZWK4=_<>']"T[2)KR..S
MMI(X[J2QMXS.BR.[`/G!8FOKO##-,RQ^*S6&.Q^(QD:-&DX1K59U%!\[3<5-
MOE=E;3H?'>*F4Y7EN%RB67Y=A\%*K7K*<J%&G2<TJ::4G"*YDGJK]34_X)\?
M#/X=>./`7CJ]\9>!?"?BJ\LO%=G;6EUX@T#3-7N+6W;289&@@EOK:5H83(2Q
M1"`6))YK'Q,S;-,NS++J>`S#$8.$\/*4HT:U2G%R51J[4))-VTNS;PMR?*LQ
MRO,JF89;AL;4I8F,82KT:=648^S3Y4YQ;2OK9=3]1O#OAGP[X1TJ'0_"VAZ5
MX=T:V>:2WTK1;"VTS3X)+B1IIWBM+2..*-I)69V(4%F8D\FOR#%8O%8VM+$8
MO$5,37DDG4JSE.;459)RDVW9*RUT1^S83!X3`T(X;!8:GA,/!MQIT81IPBV[
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M\.,\QV<97C:&8U7BJF`J0@JE364Z=6,FHS;^+E<)*\KMII.]C\K\3,AP&1YK
M@*^6T5A*6/I3FZ5/W84ZM&4$Y4TO@YE.+M&R33:2N?I%^QC\3-:^*'P+T34_
M$5Q+>ZWX>U+4/"5_J,[%Y]1_LJ*SN+&[N';F2Y.F:A91R2$DN\+NQW.:_*N/
M,IP^3\18BCA8*EA\33AB84UHJ?M>92C%=(J<).*Z)I=#]<\/LXQ&<\-8:MBI
MNIB<)4J86=1[S]DHN,F^LN2<%)]6FWJSX9_;M_:6UO5?%6H_!;P;J4^G>'/#
M[):^,;FRE>&;7M:*I+-I,DT9!_LNQ#)')"#B6X642`K`@/Z)X<\*8?#X.EGV
M.HJKBL3>6%C-7C1I*Z551>CJ5+-QE]F%K:R9^;>)?%V)KXVKP[E]9T<'A;1Q
M4H-J5:MHW2<EK[.E=*45\4[IZ11^E?PD^#'@'X<_#[0O#&E>&]&E#Z/8G6[Z
MZTVTN+S7=0FM(S>WFI330LUP996?;&Y*1IMC151`!^49WGV9YIF>(QE?%U4U
M4E[*$:DE&C!2:A"FDTH\J2U6K>K;;/U[(N'LKRC*L+@J&#I->RA[6<J<7*M-
MQ3G.HVFY<S;T>B5DDDC\@?VHM.E_9Q_:5DU7X37<WA+S]-T?Q;86>F,8+*PE
MOY+NWO\`3DM5Q')I4UQ83R&T<-%LNC&%"*H7]OX0K+BCA*-#.H+'*-2KAIRJ
M:SDJ:A*$^;=5(QFDIKWKQ3;;/P?C*B^$^,)5LBF\`Y4Z6*A&G[L(.;G&=/E6
MCI2E3;<&N6TFDDK6_5OX=O\`#7]ICX;>!OB/XM\">$O$6H7.E2VTT.NZ)INM
M-HNIV]P;76[&SDO[>5H+9M0M&E1006C:%FY-?C6:+-N$LUS'*L%F.)PE*%12
M3HU9TE5@US4IR4)).2A*S?1\R6A^VY2\GXORC+<WQV68;%U94G%JM1IU71J*
M7+6A%SBW&+G"Z76/*V?SZ6\FK6/CJ+_A&))+'6+7Q0JZ`]IMC>UU&+5`NF-:
M@J5B>*Y6$H<?*54CI7],S]E4RYK%_O,/+#7K*5VI0]G>IS=TU>_<_EJ'M:68
MIX+]UB:>)M0<4DX5%5M3Y>SC*UNQ^^WPZ_90^$GA?PU%;^*?">C>/O%NJ6PN
M/%?BKQ=91Z[J>J:M=QJ^H2P2ZD)3I]OY[.(U@V/A5:1WDRY_FS->,\[QF*<L
M'C*N68*A+EPV&PTG1ITJ<=()QA;GE9+F<KIN]DEH?T]E'`^18'!J&,P-+-,=
M7CS8G$XJ"K5:M62O-IU.;DC=OE4;-*UVWJ?BI\;M"7X+_'_QGH_@6[O-&C\(
M^*8KWPW/;W$@NM+6>VL]7LHHIR2S?9A>+""Y8LL6'W;FS^^</XEY[PU@*V80
MC7>.P[A7C**Y:C4I4I-QV3ER\VEK-Z6/YZXBPJX>XHS"AELY8=9?B%/#RC)\
MU).,*L$I;M0YN76]TK.Y^JG[-GP(T'Q_X4L?C?\`&VR@^)/C_P"(2/K,3>*8
M(]0TO0]%>62+2K/3]'F4V<1:VC2<,86$:31QQ!-C&3\=XKXCQ.68RIP[P]4>
M4Y7E;5)K#MTZE:JDG4G4JJTW:3Y;<VK3<KW5OVKA#AG"YG@J7$G$5..;YKFB
M=5/$Q52G0I7:IPITI7IQO%*5^71-*-K._P`/?MZ?"KPC\+?B9X=O?`^E6OAV
MQ\4Z"VIW&D:7&+73[74K&^EM9;BQMH\)9I,@@8Q1!(U=&95!<U^@^&^<X[-L
MGQ4,?6EB:F"KJG&I4?-.5.<.91FWK+E::O*[:=FW8_./$W)<!DV=8.674(X2
MGC:#JRITURPA4ISY'*$5I#F33M&R35TD?IM^QQX]UKXA?`+PEJWB"YFOM6TR
M74O#EQ?W#F2XOX]%NF@L[BXD/,D_V)K>-W)+.T)=B68FOR3CK+</E?$N.H86
M"I4*O)6C".D8>UC>48KHN92:6R3LM$?L7`&9XC-.%\!7Q4W4KT>>A*<G>4U2
MERQDWU?)RIO=M7>K/J*OD#[,*`"@`H`*`"@`H`*`"@`H`*`/C7QAX6\;_#_Q
MC#X\UWXZR:;X1;6DG^R:H^I37MS:^;]H?P_:>'+-&LM2S`&A#(D6Q`)652N3
M^>YA@LRRG,(YIBN)W1P#K*7)4]HYRC?F=".'A>G4]WW4THV7O-)H_-,RP&:Y
M-F<<WQ?%CH9:ZRER574<Y0OS/#PPT$Z53W;Q32C9>\TK'/>,_CQXK^&^M:?\
M4=(U*3XD?`#QAJ8T[4+5[);77O`&N1[8;BUL+C[/!)+9R&)Y(K>]#J9!+;K+
M&SPR2?O/!^$X;X^R5T,MJ1P.?82,W2JIS5'&P@WS*M3GK"K3;Y9RII6CRU.6
M:4DO.S7B_,<@Q5#B##5WGO!N9U?9U8."AB,NKJT91IRY82E"7*Y0A5NG+FIJ
M46X2EM_&#XGZS?3^%M3\'>(;JV\&ZUH%KK>C:KI$[V\>JRW$LGFM+<(`WFVX
M6)&M7*F-BV]-QP/XR\>L_P",N&>)L)DM'%XO(<%AZ'/>A)T76Q2JSC54ZL?B
M]BHT^6FI<O+-5+24TS^R?![+.%>(^'JV<>PPV<UL342C[6*J*GAG3C*FX4Y?
M#[1N:E-QYE*+IWBX-$_C?]I2]^&GPW\&QW6F-XC^+'C&T$7A[P\4>-[B-[M[
M&QUO5;>`++'!.WD".&,(]U-(5C**'>/^E?!/),\XWX4RG-^))RP%*CAW/&XJ
M<%3G4A"4_9R4&E&-2K0C&M-M<L(RYVO>C%_S_P",G$V4<#9]C\JR"DL?C<16
M4,#@X2<XPE)14^>46Y2ITZ\I4H13YJDER*2Y925"]\5>)=+\&R^!/'GQJ@T#
MXS^);C3];U*;^SY++0/"MOJ"0O;>$;34-+M`ND0&VV;[XR2R-(TI+>6X:O.\
M0<]R"KC*N2<.XR.0^Q5.G2JS]M*=:-VW5Q%;7V,J][Q<;>SIJ*:5V?`2Q^/P
MV5RRC..*8X3BC'RIUZLO9NGA\)&HHN.#A4I0M1CRVO6<I2<N9WY6F>Y_!WP'
MXS\$Z;?+XP\=W?B^:_:"2TM6FN+VPTR-`S,]K?ZAF[N))]X+9,<8$:[4)):N
M#A[*\QRVC4689I/'RJ\KC%N4X4DKZQG.]23E?7:*LK+J?6<-93F>54*JS+-I
MYE.LXN$&Y3ITDKW<)U+U).5];VBK*T;ZGR!_P40M[PZ7\,+K:[:;'?\`B:WE
M"@E%O)K+3I(0Q'`=[>"Y"^NQL=*_H7PAG36(SNG=1K.GAI1[\D9U$[>2E*-_
M5'YCXVPJ_5N'ZEFZ$:F*B[;<[ITG'YN,9I>C/O;P!>:=?^!O!M[H[Q/I=QX7
MT&2P:%E:(6ITRU$**5X&Q`$([%2#R*_*LUIUJ&9YA2Q"<:]/$UU44M'SJI+F
M;OW>I^Q9-5H5\HRNKA6GAYX3#NGRVMR>RARI6[+2W2UCKJX#TC\R/V)G6+XL
M_'61N$C^U.V.<*GBO5V.!]!7[7XE)OA_A5+=J*7_`(2T3\#\*&H\2<7MZ*/.
MW\L96.?_`&?O"NG?M(_&SXD_$/XEPC7[#09XWT_0;R1Y-/!O;Z^M]$LI8-P$
MFEZ?INGOMMN(Y)I!)*'^8/U<68ZMP9PUDN3Y++ZI5Q<7[2O!)5/<A"5::ETJ
M5:E17G\48+EBUI;CX,RZAQUQ7GN=Y]#ZY1P4E[+#S;=/WZE2-"#CUI4:5-VI
M_#*;YIIZWT/CAX;\/>%_VM?@;8>&M$TG0;*6[\$W$UGH]A;:?;R7!\67<7GR
M06L:(TQBCC3>5R1&H)XK+AC&8O&\`<4U<9B:N*J1CC(QE6G*I)1^JP?*G)MI
M7;=KVNV;<68'!9?XD\(T<#A*.#I2G@).%&G&G%R^N37,XP23E9)7M>R1)^V[
MIL6K_&CX.Z1+)+!#K&FV.D7$L#&.>.WU#Q='93-$XY2017,NT]B:7AG6EAN&
M^(\1%*4L-.=6,9*\>:GA7.-UVO%717BQ0CB>*>%\+)N,<32A1E*+M)1J8R,)
M<KZ-1D[,[/\`:Y^!GPO\(_!E-=\)^$=*\.ZIX=U71+&WNM,@\B6\T^^G%C<V
MNION)O\`<)%E$L^^021Y#?.X;S?#[B?/,=Q']5QV85<70Q=*M.4*DKJ$Z<>>
M,J:_Y=VMR\L+1<7:VBMZGB5PCP_EO"RQ>79;1P.(P-6A3C.E'E<Z=27LYPJO
M_EY>ZES3O)25T]7>'QI\3/$?AS]B#P)J-GJ-S'KGB?2]%\'MJB2NM[;Z<SZA
M!=217`.Y;AM)TLVWF9W#SRP(8`BLMR3!XSQ-S2A4HQ>%P%6MBU2:7(ZB4)13
MCMRJK4Y^7;W;/0G-<^QV!\)LHKTJ\XXO'T:&"]LFU.--NI&;4MU)T:7L^:]U
MS73NKGHG[-_[/?PVTKX1^'?$>N^%=$\1^)/%6A1Z]?ZCK=C;ZF+:#4H#=6>G
MZ?%=H\=G;PVCPAC&JN\AD=V.5">/QEQ;G.(S_&8/"XZM@\'@*[H4Z=&<J5W2
MER3J3<&G*4I)VNVHQLDEK?V^!>"LBPO#6!QN+RZACL=F&'6(J5*].-7EC5CS
MPITU--0C"#BGRI2E+FDV]+>5?\$^U5+SXR*@"HE_X95%'"JB2^)E15'90H``
M]!7O>+/\/ASNZ>(;];8:Y\[X+I1J<4)*RC5PJ2\D\4DODC])Z_&C]U"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`/B+]M?5-3UWP[X`^!_ANY
MC@\1_&/QE8:7N9G'V;0M)G@NK^[E6,AC`E[+IQ=3@-%%.,\&OT'P_HTL+BLR
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M8O)V2ZT:9BQ`5EU*WBA#=0MY(!]XY^M\1,J_M'ARO5A'FKY9*.(CWY%[E5=_
M@?-;O%=CX[PVS;^S.)L/1G+EH9I!X:7;G?OT7V7OQY;]I/N?OQ7\VG]/'\_G
M[>'_`"<UXW_Z\?!__J(:'7]+>'/_`"266_\`7S%?^I-0_E[Q+TXQS+RI83_U
M&IG[._LZP1VWP(^$4,2A47X?^&"`.,L^EV\CL?\`:9V9B?4FOP;BB3EQ%G<G
MN\9B/PJ22^Y(_H'A2,:?#611BN51P6'LO^X<6?&'_!33_D0_AI_V-FJ?^F@5
M][X2_P#(QSC_`+!:?_IU'Y]XP_\`(MR;_L*J?^F66?\`@F=_R3KXB?\`8XV/
M_IEAJ/%G_D:97_V"R_\`3K+\'_\`D4YK_P!A<?\`TTC(_P""FW_(J_"__L/:
M[_Z06=;^$O\`OF<_]>*/_IQG/XP_[GDG_7^M_P"FT;/_``3/_P"2<?$/_L<;
M+_TS0UAXL?\`(URS_L%E_P"G&=/A!_R*<U_["X_^FD?I57Y0?KI_,7HD4<_Q
MJTB"50\4OQ,LHI$/(:-_$\:NI'H5)%?UQ6;CD59Q]UQRZ;3[-85M?<?QS02>
M?T8M74LRIIKR>+BG^!_3F`%```4*,`#@`#@``=`*_D<_L;;RL?D1_P`%._\`
MD-_"'_L%>,/_`$L\/U^W>$?^ZY[_`-?<+_Z17/PGQB_WK(/^O6+_`/2\.>_?
M\$X_^2"ZM_V4C7O_`$P>%:^;\5/^2DH?]@%#_P!.USZ?PE_Y)BO_`-C#$?\`
MIK#GXN>-]0O-6\:>*]4OG=KZ_P#$FMWMV\A)D-S<ZE<S3;B>=PD=A^%?O&7T
MJ=#`8*C225.EAZ48I;<JIQ2/Y]S"K4KYACJU6_M*N)K2E??F=23=S]SM-_9J
M^(LVG:?,G[4_QAA26RM)$B1K`)$KP1LL:CS>%4$`>PK^>:O%>50JU(_ZG99)
MQG)7?M+Z-J_S/Z0H\(9M*E2DN-<UBI0BTE[.R]U67RV.`\7?L`67CW55UOQG
M\;O'_B35TM(;%=1U:PTJZNEL[=Y9(;82N^?*1YYB!ZR-ZUZ>!\2JF6T?JV`X
M?P>$H<SG[.G.I&/,TDY6[M12?HCR\=X7T\RKK$YAQ'C<77C%052K"E*7)%MQ
MC?LG)M+S9]3_``(^#6G_``)\"_\`""Z9KNH>(;-=9U#6([W4K>WMIXCJ$=JK
MVJQ6S%/*5[8R`]2TS\5\=Q'GM7B+,?[1JX:&$G[*%)PIN3B_9\UI7EK=J5GZ
M(^UX9X?I<,Y9_9E'$U,7356I54ZD8QDN?EO&T=++ENO5G\_'@:-9?CEX/B<!
MDE^*GAZ-U/0H_BVS1A_WR37]+YBW#A_'26CCEM9K_P`)96/Y<RV*EQ%@(O9Y
MG13_`/"N)_3=7\E']AG\ZG[8_P#R<Q\5/^PSI7_J-Z)7]1<"_P#)*9)_U[J?
M^GZI_*/'_P#R5V>?]?*?_J/2/W4^!$*6_P`%/A)%&-JK\./!A``QR_A^P=CC
MU+,3^-?SMQ%)RS_.F]_KN*_"M-+[DC^D^&HJ'#V1Q6B6!PO_`*8@S\R?^"FO
M_([_``S_`.Q5U3_T[FOUSPE_Y%F<?]A5'_TU(_'/&#_D:Y+_`-@E;_T]$^L?
M^"??_)NFF?\`8V>*?_2N&OBO$O\`Y*FM_P!@]#_TEGW7A=_R2=#_`+",1_Z4
MC[<K\_/T0*`"@`H`*`"@`H`*`"@`H`*`.=\2>$?#'B^TBL?$^AZ;KEK;RF:W
MBU"V2?[/*5VM)!(0'@<K\I*,N1P<BN3&8#!8^G&EC<+3Q,(.\54BGRO:\7O%
MVT=FK]3BQN78',:<:6.PE/%TX/FBJD5+E>UXO>+MH[-76Y@^*/AOX8\1?#W6
MOANNEV.G^']4T>ZTR"SM+:."WL)74R6EY;Q1`!)[>^$5RKCYO,B#$DDY]7(\
M3_J_B\!BLNIQPZP%2,X4Z:4(\J?OPLM+5(N49=U)W./,,CP&-R7%9']7A0P=
M>C.E&$(J,:;:O"<4K6E"=JB>_,KGQ%^Q!XFD2+Q_\'O%L5O=MX)U"?7=+AOX
M8KA+`)?3:7XAAA6=&\J*/4X8+A=H&#?RD?>K],\6,BR[,%DV>_4Z.*I8Z,82
M52E"HO:*"J8>HE.,DJCI2E#F6MJ<5?0_,?!O/<?@/[<X;JXJIAZF6RE4AR3E
M3<8>TE2Q-.\6G[-58QFH[7J2=M3G_P!GR)_CK^TUXY^+6M(;K2?!S/+X<@E`
MD@M'EGN-)\*11J?E46VE6E]>*5'_`!\2B7`8UZW%C7"W!.5</86U.OCTEB''
M1R48QJXE_P#;U65.G_U[CR['D\%I\7\?9QQ+BTZF'RMMX:,M8P;E*CA$O\%*
M%2KI_P`O)<^Y^AFO_#WP/XIOK;4_$7A;1=8O[15C@N[^QAGF$:,72)V9?WT*
ML21')O49.!R:_`\5E.6XVK"MB\#1Q%6G91E.";LM4FWND]D[KR/VO&9-E6/J
MTZ^-R^AB:U))1G4IQ<K)W2;?Q)/5)W2['7HB1(D<:+''&JHB(H1$1`%5$50`
MJJH`````%=Z2BDDN51T26B26R2Z6/1244HQ2BHJR2T22T226R1YA\8?A9HOQ
MA\#:EX,UB1K1IFBO=(U6*,23Z/K%H'-E?Q1L0)5&^2*6(LOF0SRIE2P9?<X>
MSS$\.YI0S'#)3Y+PJTF[1JT96YZ;:O;9.,K>[.,96=K/P.)N'L)Q-E%?*\4W
M3YFIT:L5>5&M"_LZB3M=*[C*-US0E*-U>Z^#?",W[6O[-4<WA&U\"?\`"R?!
M=O-.^E_88KO5[&U265G>32[O3I!?:5!+(QD-G>6S(CR.8U&XLWZGF$>`.,G'
M,)YI_8F92455YW&E.32LE4A47LJLHK15*<TVDN9Z67X]EDO$G@.,LLIY/_;N
M54Y2='V:G6IP3=VZ4Z;]M1C)ZNE5IN,9-\J5VW]4?`SXF?&KX@Z[KG_"Q?A@
M?A[X;L])@DTB6:UU&"YU#5)+P)+&9=1E5I(DM0S82UC`)Y<G`KX7B?)>&\HP
MN%_L?._[7QE2K)55&5-QITE"\7:FFDW+36;?EU/T3A'/N*LZQ>+_`+;X?_L3
M`T:,71<HU8SJ57.S5ZK3:4+O2FEW;V/%/V1?A]XX\)?$[XPZCXJ\(Z]X?TS6
M#.-+O=7T^2UM=1#>)=3N0+623B8&VECDX_A<'H:^FX_S?*\?DG#E#`YA0Q=;
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M.F:3;-=7DD5OJ44L\B0IR4CC!9CV`KYK@#&X/+^)<-B<=B:>$P\*5=.I5ER0
M3E3:BFWU;T7F?5>).`QN8\*8K"9?A*N,Q,JV&E&E1CSS:C5BY-172*5WV1YQ
M)\$?$?CW]D#PE\/+FPFT+QMHFF6FK:=I>LH;&2+6M,U"_E33;\2#-J+JSN)H
M0[<(UQ&[?*IKV(\38/*O$+'YQ3JK$Y;B*LZ52I1?.G1J0@G4A;XN2<8RLM6H
MM+5H\.7">.SCPSRW(YT7A,UPE*%:G2K+V;5>E4J-4ZE_@]I"4HW>D7*+>B9Y
M1\/_`(A_M0:'X)M/@C8_!C55UVSLY/#>E^,M7BO;&PT32YR]O%>ZA*T)L;G[
M#!-B*XCO`CK%$?+D8;9?>S;*.!\3F53B6IQ)2^JU)K$5<'2<)U*U6-I.%-)J
MK'VLE[T)4^:+<O>BM8_.Y+G7B!@\II<)TN%JRQ=&#PM+'5E.G3H4I7C&I4?*
MZ4O8Q?N3C5Y9*,?=D])=I^R!\/\`QY\)]:^,FE>(_"FN1P1C3_[&U2>RDM+'
MQ1+H5QKEL6TBYGXF6Z6:*:,MSLG1CUKS?$+-\KSW#<.8C!8ZBYVJ>VI1FI3P
MRK1HRM5C'9PY7&5NL6D>KX99+G'#>+XHPV.R^O&$?9>PK2@X4\6\/*O"]&4M
M_:*2E&_V9)L^\]*N[B^TZSN[JQFTRYGA62:PG8/-:R'.8G90`2,>@X(R`>*_
M*ZT(TJLZ<*BJPB[*:5E)+JDS]AH5)U:-.I4I.A.44W3EJX/LVC0K,U"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`^%/!Y/Q:_;-\;>*V#3^&O@3
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M@_GRI_,_I6^&?C.T^(?P_P#"'C6R(,/B/0=/U)E&W,-S+`HO;=@IPKPW:SQ,
MO8QD=J_E'-L!/*\SQV7U%:6$K3IK_"G[K]'&S3\S^O,GS"GFN5X#,:3]S%T:
M=3TDXKFCY.,KIKI8_#7]O#C]IKQOV_T'P?[=/"&AU_0OAS_R266_]?,5_P"I
M-0_G#Q+_`.2QS/\`Z]83_P!1J9^T7[/G'P-^$G;_`(M]X5]O^81:U^"\2_\`
M)0YU_P!AF(_].2/Z#X6TX<R/I_L6&_\`343XK_X*:?\`(A_#3V\6:I^&-(%?
M?>$O_(QSC_L%I_\`IU'YYXP_\BW)O^PJI_Z999_X)G<?#KXB=O\`BL;'VZ:+
M!4>+/_(TRORPLO\`TZR_!_\`Y%.:_P#87'_TTB+_`(*8:7<S>`?AWJT4;M:V
M'BK4+.Y=59EA>_TLR6[2,!A%;[%*H)P,X'4BJ\)JL(YCFM!M*=3#0E%=^2JN
M:WHI)^ER?&"C-Y9E%=)\E'%3A)]%STGRW]7&WK87_@F;/"WP_P#B/;+(IG@\
M6Z9++$"-Z13Z1LA=AV5VMYP#W,3>AI>+,9+,\JG:T98::3Z7C4U7RNK^J'X/
MRC_9>;037-'%0;75)TO==O.SMZ,^]]#^(WA7Q'XQ\7>!='O)KO7_``*FEGQ*
MB6LHLK"36+<W-C;?;L>5+=F%7+1*2R&-@V"I`_.,1E>,PF!P.85Z:IX;,/:>
MP;DN::I2Y9RY-U%/12>CTMN?IN&S;!8O'X[+</4<\5EBI^W2B^2#JQYH1Y_A
M<K:N*U5G?8_G(\/?\EOT3_LJ&G_^I3%7]35],AK]+9;4_P#421_)F&_Y*'#_
M`/8SI_\`J7$_IPK^2#^Q3\A_^"G?&M_"#M_Q*O&'MTO/#]?MWA'_`+KGOE5P
MO_I%<_"?&+3%9!T_=8O_`-*PY[]_P3CX^`FK=O\`BY&O>W30/"E?-^*G_)24
M/^P"A_Z=KGT_A+_R3%?_`+&&(_\`36'/S:_:\^#^I?"?XQ^(V^R2)X7\7:A>
M>)O#%ZJ,+9[?4IVN;[3@^-JW%A?3RP-'G/E^1)TE%?JG!&=TLYR+">^GB\!"
M.'Q$+^\G!<L*EOY:D$FGMS<T>A^2<=Y%6R+/\7^[:P>/G+$8:=O=:F^:=._\
MU*;<6M^7EEU/WM^'GB/3/%O@3PAXET:XCN=-UGP[I-]:RQL&`62RA\R%B#\L
ML,HDB=3RKQ,I`*D5_-^9X6K@LQQN$KQ<*N'KU(235MI.S]&K-/JFFC^F\JQ=
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MNS1EPS#-(9'@'G-:5?,JL/:UG-14HNI)SC3:BHI.G!Q@]/B3/Y]/`7_)=O!?
M_96/#?\`ZE]E7],9G_R3N/\`++:W_J+(_EO*_P#DI,N_[&E#_P!2XG]-=?R6
M?V$?SJ?MC\?M,?%3M_Q.=*]O^9;T2OZBX%_Y)3)/^O=3_P!/U3^4>/\`3B[/
M.G[RG_ZCTC]V?@>,?!CX3=L?#?P5[8_XIS3L5_.G$'_(]SGRQV*_]/S/Z5X<
MTX?R3I_L&$_],0/S$_X*:\>-OAGV_P"*5U3VZ:N:_7O"7_D69QY8JC_Z:D?C
M7C!IFN2]/]DK?^GHGUC_`,$^^/V=-,[?\59XI]NEW#7Q7B7_`,E36_[!\/\`
M^DL^Z\+M.$J'3_:,1_Z4CUC5?CO!IGB&2Q_L*231[=KII;@7=N-3FTZP_M1M
M0UJVL/,#FQMH]%U-]GEN76",^9&;B-3XM'AR57"JI]84:\N6T>5^S4Y^S4*4
MIVMSR=6FKW5FWH^5L]NOQ+&ABG2^K-X>/->7-'VCA#VG/5C"]^2"I5':S;44
M[KFBCZ$KYD^I"@`H`*`"@`H`*`"@`H`*`.'\2?$OP!X1W+XB\6Z'I<JYS:RW
MT4MZ"!G'V&W,D^?3]WSVKS,9G.58#3%X^C0DOLN:<_\`P"-Y?@>5C<\RC+;_
M`%W,:%"4?L.HG/\`\`C>?_DIY3-^U+\+3=0V>F2>(M;>>XAMXY=,T*Y-N7FE
M6)6,EVT!"`L"3LS@=*\.7&^1\\:=%U\2Y244Z="7+=M):RY=->Q\_+C[(/:1
MI4'B<4Y2C%.EAY<MVTEK/ET5^Q\1Z#/-X:_:G_:%CT\F%6\(_%^\V1_*!(-)
MM];AP%Z;;DY'H37]58N$<9P)PBZJYG'%Y5#7M[65%_?$_),'.6!\0^-8T'RI
MX/.9V7?V,:ZV[3V.F_8T\:Z'\,OA7XU\7:Y:ZI=6^I^/-'T)AI%F+VZB,/AX
MW4+R1&6/%NI>XR=WWI``.:^+\<LZH9/C<FGBH59T51G%*E#GDI3JSNVKK2U-
M*_H>CX69GA,BX=S7,L53JSA7S"C0?L8<\U;#<T6XW7NJ\NN[\S[,T?\`:5^#
MVK.L+^)SHT[$`0:[I][II!/`#3/"T"<_WI17XAA^,>'\0U'Z[]7E_+6A.G^+
M3BOG(_4L-QQPUB6H/'_59O[->G.E_P"3-."^<CV;2]8TC6K9;S1M3T_5;1L;
M;C3KRWO8>1D#S+>1U#8[$YKZ*AB*&)@JF'K0KT^DJ<XS7WQ;1]-0Q.'Q4%5P
MM>G7IO:5.<9Q^^+:-*MC<*`"@`H`^1?B9_PUYI_CC6[CX7)X.UCP+=K8-H]E
MJ[Z5'?Z=*NGVT5^':Y:TD*-?I/(H::<8?C:#M'W^2?\`$/ZN68:&>/&8;-*;
MJ>UG151TZB]I)T[*/M$FH.*=HQ>G7<_-L_\`^(E4,VQ4^'E@L3E%14_8TZSI
M*I2:I152_,Z<K.HI25YS5GTV.(^$O[//Q3U+XKP_&GX]:SIUWKNE_O-&T33I
MXKH)=QP26]E)*;2)+2PT^QCGF>&UMC*6F822/D'S/3S_`(NR+#Y#+AKA7#5*
M>$KZ5JU2+C>/,I324FZDYU'&*G.?*E!<L5;;R.&^">(<1Q'#BKC'%4JF,PVM
M"A2DIVFHN--MP2I4Z=%2DX4Z?,W-\TI7OS?>-?EI^P!0`4`%`!0`4`%`!0`4
M`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!Y1\3OAYXE\>'0O^$=^*/BSX
M:_V1_:1N_P#A%XM/E_MK[=_9_P!G^W"^C?'V/['-Y6S&?M\N[H*]K)\TPF6?
M6/K638;-_;^SY/K#J+V/)S\W)[.4?CYES7O\$;=3P\YRG&9G]6^J9WBLF^K^
MTY_JRIOVW/R<O/[2,OX?(^6UOCE?H?/?A3]CW7/`XU@>$_VA?B5H?]OZG)K.
MLM9V6A!]1U248DO;J22)GDF89_BQR2.6.?I\9QUAL?[#Z[PME^)^JTU2I*<Z
M]J=-;0BE-))?>?*8+@#%9;[?ZCQ9F.%^M5'5K.$,/>I4>CG)N#;?X>1]@>&M
M*O-"T#1]'O\`6K[Q%>Z9I]M9W6O:FL*:AJT\$:I)?WBVZK&MQ,P+L$4+D\"O
MAL76AB,37KTL/#"4ZLY2C1IWY*2;NH0YFWRQV5W<^_P="IA<+A\/5Q$\74H0
MC"5:I95*KBK.<^5*/-+=V21Y]\3OAQXG\>2Z/)X>^*OB_P"&R:7'>I=1>%XM
M.D35VNFMFADO#?1.0]N()%CV$#%S)D9QCT\GS7!Y;&NL5DN%S;VSARO$.HG2
MY>:ZA[.4?BNKWO\`"K'DYSE&-S.6'>$SW%Y.J"FI+#*FU5YN6SG[2,O@Y7RV
MM\3N?(OB3_@GAX=\7ZW?^(_$OQ;\:ZOKFJ2B?4-2NM,T3[1=S+&D0EF,:*&?
MRXT!.,G;D\U]OA?$_$X+#TL+A,CPE##4%:%.-2MRQ5[V5Y-VN^Y\+B_"G"XW
M$5<7B\_QE?$UG>=25.AS2:5KNT4KV78]$\)_LE>)O`NAVOAKPE^T9\3]"T*P
M>X>STRRM-#6VMVNIY+FX\I9(6*AYY9'(!QER0.:\O&<;8/,,1/%8WA3+L3B:
MG*I5)RK\SY4HQO::6D4EMT/4P7`N-RW#4\'@>+\RPN%I7Y*<(8?ECS-R=KP;
M5VV]^IP?BS_@GWHWCK7;KQ-XN^,7CK7M>O5MDN]3O].T5[F=+.VBL[979448
MCMH(8Q@=(Q7I8+Q,KY=AX83`Y#@\+AJ3DX4X3K*,7*3E)J\GO)MOS/-QOA90
MS'$SQ>/XAQN*Q5114JDZ=#F:A%1BG:*7NQ22TV1]!_";X%>(?A;>Z0I^,OCC
MQ5X:T/2'T?3_``AK-OI46CPVZ0+;V94VL0E!M40>6-W;DD<5\QG7$>%S>E6M
MD&#P.+KU55GB:4JKJN5VY+WI./OM^]IZ'U.1\-8O):M"_$6-QV#PU)TJ>%K1
MHJC&-E&%N2*E[B7NZ^IY3\0_V,[SXIK#!XX^.WQ#UVPL[^ZU#3=/O;'1)+;3
MI;G<I%N%C4C;"1'D]EZ#I7M99Q[3R>\LNX;P.%J2A&G4G"==2J*%OBO)K62Y
MG:VIXF:>'M3.;1S+B?'XJE3J2J4Z<X4'&DY7TC:*>D7RJ_1!X`_8SOOA?!/9
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M3E_>UY5(RUA9J$8V45)[O5^&P_\`!.'PC;:I%K4/Q5\9QZK!?)J<5\NFZ,)T
MOXYQ=)=*V/\`6K<`.#CJ*^B?BICG2=!Y+A'1E!TW#GK6]FX\CAOLX^[Z'S<?
M"/`PK1Q$<\QD:T9JJI^SHW512YU/;=25_4^P_`GPV\4^$M'\4:;K/Q:\8^-[
MK7K=8=.U;78=-CO/#3K:WEN;C2UM80C2F2YBF/F@KNLXL#!;=\+F6;8/&U\'
M5P^287+885WG2H.IR5US1E:ISR;LE%Q]VVDGY'WV5Y/C<!A\;1Q.?8O,YXI6
MIU:ZI*>']V4;TN2*5[R4O>3UBNA\U>.OV'6^)DNFS>/?CI\0O$\NCQW,.FOJ
M=AHCFSCNWBDN4AV1K@2/!"3G/^K'I7UN7^(:RF-6.6\-X'!1KN+J*G.NE)P3
M46[R?PJ32]6?'YCX;/-W1EF?$^/QLL.I1INI"A>"E9R2M%;N*OZ(Z7X;_LC:
MI\*H[/3_``A\=_B'IN@0:W#KEWX?@LM%CT[4;A6LUNH[D"(N%N;:RA@<J?N*
M,#CGDS3C>CG#J5,=PU@:V)E1=&%>4JSJ4XVER./O)7A*3E&Z>NYV93P'7R14
MZ6`XHQ]#"PK*M*A&%!4ZDKQYU+W6[5(P4)6>VVI](_$?X8^"?BQX;G\*^.M%
M@UC2Y"98&8F"^TZZV%$O=,O8\2V5VJL1O0X895U9"5/R>59OF&28N.,RW$.A
M6CHUO"<>L*D'I*+[/;=-/4^OS?)LNSO"2P.98:->C+6/2=.6RG3FM827=;[-
M-:'REX>_94^*WPM6;2_@Q^T)JOAWPM/<S70\/>)O#=CXAM[.2=R6^R%IECA?
M&"7ABM_,;+2*S?,?L\5QEDV<<M7/>%Z6(QD8J+KX>O.A*26W,DG==DW*RT31
M\3A."<[R12H\/<55<)@92<EA\30A7C!O^1MJS[M*-WJTV>C^$_V:8_\`A)M,
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MI3]I&3O&S2M;1NY\?6G_``3B\)6&JVNN6?Q5\:6^KV6H0:K:W\>FZ,)X-1MK
ME;N"[1L8$J7*)(#CJHK[B?BIC:E&6'J9+A)4)P=*4'.M9TW'D<7KLXZ>A\'3
M\),#2K0Q-//<9"O3FJL9JG1YHU(RYU-:;J2OZGU):?!_QM;>"=6\*R_';X@7
M>KZAK%IJ=MXREM]'&MZ7:VR(DND6D:VXA-E.4+.7!?+G:0,`?'SSW+Y9C1QL
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M`X.G5DI3C3G72E)*R;O)ZI:'S>8^&G]K3I5<SXFQ^-J4(N$)5(4+QBW=I6BM
M&U<[7X9_LIZQ\*?[%L/#'QU^(4'AG2-:BUF7PLMEHD>E:D?M<-S?6ET!"SB"
M\6'RI2ISM=MN#@CS\VXSH9S]8J8OAO`RQ=>DZ2Q/-6=6G[KC"4?>Y;PO>-U:
M^YZ63\$8C)'AJ>#XGQ\<%AZJJO"\E!4JGO*4X2M#F49VM*SO;8]EO/@_H]YJ
M-U+_`&C=Q:+?W4UW?Z.D,)FD-R+M;W3K;5\BXM-#NUOKU;BQ"NLBWDR[U!3R
MO`IYW7ITH1]E%UZ45&%2[LN7EY)RI_#*K#D@X5-.5QB[/6_T-3(</.K-^UE'
M#U9.4Z22N^;FYZ<:OQ1HSYYJ=-)J2E)76EO7J\0]T*`"@`H`*`"@`H`*`(IS
M,L,AMHXY)U4^5'+(T,3/T422+'(43/4A&..@)J9<RB^1)R2T3=E?I=I.R[V3
M]"9<RB^1)R2T3=E?I=I.R[V3]#S/5/`&L>*BZ^+/&>M+IS\'P[X1E;PUIA0]
M8KS4(6DU34EP.2;JW0GD1+TKQZ^58C&W6.S&M&B_^7&%?U>G;M.HFZU3S]^"
M_NH\/$91B<?=9AF=:-!_\P^$?U:E;M.I%RKU//\`>0B_Y%L2:+\&OA=H!#Z=
MX(T$SC!:ZO[-=5NW<=9'N=3-Q(9">2VX$FGAN'LDPFM'+*',OM3A[65^[E4Y
MG?SN5A>&<AP6M'*L/SK[<X*K._=RJ\\K]W<]`M=-TZQ`6RL+*S5>%6UM8+<`
M#H`(HUQ7JPHT:6E*E"FELHQC'\DCUZ="C15J5&%)+90C&/Y)'YH?!W0!\0?V
MG?VC=6B^;3XM,\<Z%'<8S'YFOWR:#;(3T#-:Z?=O](FK]PXBQ?\`9'!'!V'?
MNUI5,'7<>MJ$'7D_E*I!?,_!N%\'_;7'_'&)CK1C2Q^'4NE\146'BO5PI3?R
M9UW_``3^E:UT#XI^&+M0EYH_BG37N+9QRADL)].F5E8?PW.DS+SZ5Y_BS"-7
M%9'C8>]2Q.%J*+Z-*:J+_P`EJIGI^#$G2P7$.7U%RU<)BZ7-%]+TY4W=>4J,
MD?=VH>$_"^JHT>J>'-"U!&&&6]TFPN<Y]YH&-?C-7`X*NG&M@Z-5/I.E"7YQ
M9^OULOP&(3C7P5"LGTG1IR_]*BSSV;X$_#N*Z_M'P_8:CX+U16W+J7@W5[[0
MIPW;=;PRM:3*/[DMNZ=BM>3+AC*8S]KA*53+JZVJ82K.@_\`P&+=-^DH->1X
M\N$\FC4]M@Z-3*ZZVJ8.M4H2^<8MTY+RE!KR.UT'3O%6D.MIJ>NV_B;3E4K'
M?7EE'IVNP;1A%N6L1]CU(8`!D6"S?DD^8:]+"T<;AVJ=;%1QE);3G!4ZT>W-
MR?NZGJHTWU?,>IA*./PS5*OBXXZBMJDX*E7CVYO9_NJGJH4GU?,=;7<>@%`!
M0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`
M%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0
M`4`?+O[2?Q:^+_PM_P"$+_X53\*]2^)G]N?\)%_;W]G^'O$VN_V)_9?]A?V7
MYW_".QM]D^V?VAJ.W[1C?]@;R_\`5O7V'">2Y%F_U_\`MK.891]6]A['FJX>
ME[7VGMO:6]O*/-[/DA?EO;G][='QG%V>9_DO]G_V'DD\X^L^W]MR4<15]C[/
MV/L[_5XRY?:<]2W/:_(^79GR[_PUK^U[_P!&K^)/_#??$O\`^1Z^P_U*X%_Z
M+*E_X58#_P"6'Q?^O/'W_1$UO_"/,/\`Y6'_``UK^U[_`-&K^)/_``WWQ+_^
M1Z/]2N!?^BRI?^%6`_\`E@?Z\\??]$36_P#"/,/_`)6'_#6O[7O_`$:OXD_\
M-]\2_P#Y'H_U*X%_Z+*E_P"%6`_^6!_KSQ]_T1-;_P`(\P_^5A_PUK^U[_T:
MOXD_\-]\2_\`Y'H_U*X%_P"BRI?^%6`_^6!_KSQ]_P!$36_\(\P_^5A_PUK^
MU[_T:OXD_P##??$O_P"1Z/\`4K@7_HLJ7_A5@/\`Y8'^O/'W_1$UO_"/,/\`
MY6'_``UK^U[_`-&K^)/_``WWQ+_^1Z/]2N!?^BRI?^%6`_\`E@?Z\\??]$36
M_P#"/,/_`)6'_#6O[7O_`$:OXD_\-]\2_P#Y'H_U*X%_Z+*E_P"%6`_^6!_K
MSQ]_T1-;_P`(\P_^5A_PUK^U[_T:OXD_\-]\2_\`Y'H_U*X%_P"BRI?^%6`_
M^6!_KSQ]_P!$36_\(\P_^5A_PUK^U[_T:OXD_P##??$O_P"1Z/\`4K@7_HLJ
M7_A5@/\`Y8'^O/'W_1$UO_"/,/\`Y6'_``UK^U[_`-&K^)/_``WWQ+_^1Z/]
M2N!?^BRI?^%6`_\`E@?Z\\??]$36_P#"/,/_`)6'_#6O[7O_`$:OXD_\-]\2
M_P#Y'H_U*X%_Z+*E_P"%6`_^6!_KSQ]_T1-;_P`(\P_^5A_PUK^U[_T:OXD_
M\-]\2_\`Y'H_U*X%_P"BRI?^%6`_^6!_KSQ]_P!$36_\(\P_^5A_PUK^U[_T
M:OXD_P##??$O_P"1Z/\`4K@7_HLJ7_A5@/\`Y8'^O/'W_1$UO_"/,/\`Y6'_
M``UK^U[_`-&K^)/_``WWQ+_^1Z/]2N!?^BRI?^%6`_\`E@?Z\\??]$36_P#"
M/,/_`)6'_#6O[7O_`$:OXD_\-]\2_P#Y'H_U*X%_Z+*E_P"%6`_^6!_KSQ]_
MT1-;_P`(\P_^5A_PUK^U[_T:OXD_\-]\2_\`Y'H_U*X%_P"BRI?^%6`_^6!_
MKSQ]_P!$36_\(\P_^5A_PUK^U[_T:OXD_P##??$O_P"1Z/\`4K@7_HLJ7_A5
M@/\`Y8'^O/'W_1$UO_"/,/\`Y6'_``UK^U[_`-&K^)/_``WWQ+_^1Z/]2N!?
M^BRI?^%6`_\`E@?Z\\??]$36_P#"/,/_`)6'_#6O[7O_`$:OXD_\-]\2_P#Y
M'H_U*X%_Z+*E_P"%6`_^6!_KSQ]_T1-;_P`(\P_^5A_PUK^U[_T:OXD_\-]\
M2_\`Y'H_U*X%_P"BRI?^%6`_^6!_KSQ]_P!$36_\(\P_^5A_PUK^U[_T:OXD
M_P##??$O_P"1Z/\`4K@7_HLJ7_A5@/\`Y8'^O/'W_1$UO_"/,/\`Y6'_``UK
M^U[_`-&K^)/_``WWQ+_^1Z/]2N!?^BRI?^%6`_\`E@?Z\\??]$36_P#"/,/_
M`)6'_#6O[7O_`$:OXD_\-]\2_P#Y'H_U*X%_Z+*E_P"%6`_^6!_KSQ]_T1-;
M_P`(\P_^5A_PUK^U[_T:OXD_\-]\2_\`Y'H_U*X%_P"BRI?^%6`_^6!_KSQ]
M_P!$36_\(\P_^5A_PUK^U[_T:OXD_P##??$O_P"1Z/\`4K@7_HLJ7_A5@/\`
MY8'^O/'W_1$UO_"/,/\`Y6>F_!_]H+]IOQ]\0=!\->+?@'?^"/#-W)<2ZUXC
MU?PIXWT6WL+*VM9IB(;S6$2V-W+*D4,<;$EFEX!P:\C/.&>$,MRO$XO`\2QQ
M^,IJ*HT*=?"5'.<I):QI2E/EC&\I-+2V^I[&0<4\9YEFN%P>/X7EEN"FY.MB
M*F'QE)0A"+>DJL8PYY.T8IO6[TT/O>OS8_3PH`*`"@`H`*`"@`H`*`"@`H`*
M`"@#Q7X,_!?2_@_;>+C;ZC)K.K>,_%6I^(]4U.6V%JPAN;JXETW3(XA-)^ZM
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MVFOFSZD*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*
M`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`
MH`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`
M"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@`H
3`*`"@`H`*`"@`H`*`"@`H`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
